| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 2001 |
PCR36 Building a COA Strategy in Allergic Fungal Rhinosinusitis: Patient Experiences and Clinical Outcome Assessments from the Literature
|
Klooster, B.
|
|
|
26 |
12S |
p. S455
|
artikel
|
| 2002 |
PCR254 Building a COA Strategy in Chronic Rhinosinusitis with or Without Nasal Polyps: Patient Experiences and Clinical Outcome Assessments from the Literature
|
Klooster, B.
|
|
|
26 |
12S |
p. S498
|
artikel
|
| 2003 |
PCR200 Characteristics at Baseline of Patients with Asthma and Prior Systemic Corticosteroid Use Initiating Dupilumab Enrolled in the Real-World Study Rapid
|
Lugogo, N.L.
|
|
|
26 |
12S |
p. S487-S488
|
artikel
|
| 2004 |
PCR112 Characteristics of Individuals Living with Obesity in Germany, Weight-Loss Methods Attempted and Healthcare Resource Use over a 12-Month Period
|
McMillan, A.
|
|
|
26 |
12S |
p. S470
|
artikel
|
| 2005 |
PCR206 Characterization of the Lupus Patient Experience Based on Longitudinal Patient Generated Real World Data from a Digital Health App (HEALTH STORYLINES)
|
Willmon, R.
|
|
|
26 |
12S |
p. S489
|
artikel
|
| 2006 |
PCR223 Characterizing Spillover Effects and Carer Burden in X-Linked Hypophosphatemia
|
Lawrence, C.
|
|
|
26 |
12S |
p. S491-S492
|
artikel
|
| 2007 |
PCR87 Collecting Exploratory Patient Preference Data Using an Efficient Approach: An Example in Rare Diseases
|
Ho, K.A.
|
|
|
26 |
12S |
p. S466
|
artikel
|
| 2008 |
PCR159 Considerations for Maximizing the Research Value of PRO Data Collected in Clinical Care
|
Maruszczyk, K.
|
|
|
26 |
12S |
p. S479
|
artikel
|
| 2009 |
PCR12 Construct Validity of a New Migraine Satisfaction with Treatment Questionnaire
|
Ruiz, M.A.
|
|
|
26 |
12S |
p. S450
|
artikel
|
| 2010 |
PCR47 Consumer Preferences for Attributes of Influenza Vaccines in the United States: Results from a Discrete-Choice Experiment Study
|
Poulos, C.
|
|
|
26 |
12S |
p. S457
|
artikel
|
| 2011 |
PCR192 Content Validity of the EQ-5D and Health Utilities Index (HUI) to Assess Health-Related Quality-of-Life (HRQoL) Impact in Duchenne Muscular Dystrophy (DMD)
|
Szabo, S.
|
|
|
26 |
12S |
p. S486
|
artikel
|
| 2012 |
PCR244 Core Oncology Outcome Strategies: Do They Offer an Opportunity for Simplicity and Consistency, or Pose a Risk to Comprehensive Understanding of Patient Experiences?
|
Gaspar, L.
|
|
|
26 |
12S |
p. S496
|
artikel
|
| 2013 |
PCR132 Correlation Between Quality of Life (QoL) of Patients Treated With Nivolumab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck (R/M SCCHN) and Their Caregivers
|
Baumstarck, K.
|
|
|
26 |
12S |
p. S474
|
artikel
|
| 2014 |
PCR256 Correlation of Patient-Reported Vitiligo Noticeability Scale With Physician-Assessed Facial Vitiligo Area Scoring Index Responses: Post Hoc Analyses From the True-V Trials of Ruxolitinib Cream in Vitiligo
|
Wolkerstorfer, A.
|
|
|
26 |
12S |
p. S499
|
artikel
|
| 2015 |
PCR224 Corticosteroids Usage Impact on Inflammatory Bowel Disease Patients, in Portugal
|
Dias, A.
|
|
|
26 |
12S |
p. S492
|
artikel
|
| 2016 |
PCR118 Cross-Sectional Measurement Properties of the Physical Distancing Scale – COVID-19 (PDS-C19) Self- and Observer-Reported Measure of Physical Distancing Behaviors to Avoid COVID-19 in Adults, Children, and Caregivers
|
Powell, P.
|
|
|
26 |
12S |
p. S471
|
artikel
|
| 2017 |
PCR263 Design of a Patient-Informed Chronic Kidney Disease (CKD) Experience Interview Guide: Learnings From DISCOVER CKD
|
Ofori-Asenso, R.
|
|
|
26 |
12S |
p. S500
|
artikel
|
| 2018 |
PCR269 Detecting Changes in Relative Weighting of EQ-5D Dimensions and Levels with Sequential Analytical Hierarchy Process in Hong Kong Sar, China
|
Ng, C.C.W.
|
|
|
26 |
12S |
p. S501
|
artikel
|
| 2019 |
PCR149 Determination of Ranges of HiSQOL Scores Defining Clinically Meaningful Within-Patient Improvement Thresholds and Severity Levels
|
Kirby, J.S.
|
|
|
26 |
12S |
p. S477
|
artikel
|
| 2020 |
PCR205 Determination of Ranges of HSSDD & HSSQ Scores Defining Clinically Meaningful Within-Patient Improvement Thresholds and Severity Levels
|
Ingram, J.R.
|
|
|
26 |
12S |
p. S489
|
artikel
|
| 2021 |
PCR270 Development of a Quality Appraisal Tool for Systematic Literature Reviews of Studies Eliciting Health State Utility Values (HSUVs): A Delphi Consensus Approach
|
Muchadeyi, M.
|
|
|
26 |
12S |
p. S501-S502
|
artikel
|
| 2022 |
PCR168 Diabetes Mellitus Type 1 in Chile: Unveiling the Patient Journey Throughout Coverage Schemes in Young People and Adults
|
Obach, A.
|
|
|
26 |
12S |
p. S481
|
artikel
|
| 2023 |
PCR81 Diagnosis and Treatment Patterns in European Patients with Systemic Mastocytosis
|
Triggiani, M.
|
|
|
26 |
12S |
p. S464
|
artikel
|
| 2024 |
PCR227 Do Family Spillover Effects of Illness Vary With the Age of the Ill Individual?
|
Cadham, C.
|
|
|
26 |
12S |
p. S492-S493
|
artikel
|
| 2025 |
PCR235 Drivers of Treatment Preferences in High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) Patients: Qualitative Interviews to Inform a Patient-Preference Study
|
Mason, B.
|
|
|
26 |
12S |
p. S494-S495
|
artikel
|
| 2026 |
PCR145 Dupilumab Reduces Systemic Corticosteroid Use in Children with Uncontrolled Moderate-to-Severe Asthma Regardless of Prior Exacerbation History
|
Ducharme, F.M.
|
|
|
26 |
12S |
p. S477
|
artikel
|
| 2027 |
PCR252 Early Steps Towards a Huntington's Disease Burden-of-Illness Model: Estimating Out-of-Pocket Costs for Patients Showing Clinical Symptoms
|
Hamilton, J.
|
|
|
26 |
12S |
p. S498
|
artikel
|
| 2028 |
PCR251 Economic and Humanistic Burden of Visual Impairment and Blindness in Patiens and Their Caregivers with Retinitis Pigmentosa or Leber Congenital Amaurosis (E-BIRDS Study)
|
Blanch Mur, C.
|
|
|
26 |
12S |
p. S498
|
artikel
|
| 2029 |
PCR210 Effectiveness of a Decision Aid for Parents/Caregivers of Children Needing Enteral Support
|
Rivero, C.
|
|
|
26 |
12S |
p. S489-S490
|
artikel
|
| 2030 |
PCR271 Employing Episodic Future Thinking to Reduce the Distortion of Time Preference in Time Trade-Off Valuation
|
Lang, Z.
|
|
|
26 |
12S |
p. S502
|
artikel
|
| 2031 |
PCR113 EQ-5D Studies in Pediaric Diabetes: A Systematic Review
|
Péntek, M.
|
|
|
26 |
12S |
p. S470
|
artikel
|
| 2032 |
PCR3 EQ-5D Utilities for Patients With Nonalcoholic Steatohepatitis (NASH): A Comparison of Historical Utilities to a Recent Real-World Multi-Country Patient Survey
|
Fishman, J.
|
|
|
26 |
12S |
p. S448
|
artikel
|
| 2033 |
PCR64 EQ-5D Utility Scores in Patients With Clinically Suspect Arthralgia (CSA): Differences Between Progressors and Non-Progressors
|
Bour, S.S.
|
|
|
26 |
12S |
p. S461
|
artikel
|
| 2034 |
PCR78 Establishing Meaningful Change Thresholds for EORTC QLQ-CLL17 Domain Scores: An Analysis Based on the TRANSCEND CLL 004 Study in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
|
Eliason, L.
|
|
|
26 |
12S |
p. S464
|
artikel
|
| 2035 |
PCR176 Establishing the Interchangeability Between CSF and PET to Identify Patients With Alzheimer's Disease Pathology
|
Burnham, S.C.
|
|
|
26 |
12S |
p. S483
|
artikel
|
| 2036 |
PCR86 Estimating Health-Related Quality of Life in Fabry Disease for Patients Treated with Enzyme-Replacement Therapy in the BALANCE Randomized Controlled Trial
|
Lee, B.
|
|
|
26 |
12S |
p. S465
|
artikel
|
| 2037 |
PCR201 Estimating the Respiratory Syncytial Virus (RSV) Health Utility Values for Older Adults and Their Caregivers in the Japanese Population: A Time Trade-Off (TTO) Study
|
Rendas-Baum, R.
|
|
|
26 |
12S |
p. S488
|
artikel
|
| 2038 |
PCR68 Estimation of Minimal Clinically Important Difference (MCID) for the Tardive Dyskinesia Impact Scale (TDIS), a Tardive Dyskinesia-Specific Patient-Reported Outcome
|
Farber, R.H.
|
|
|
26 |
12S |
p. S462
|
artikel
|
| 2039 |
PCR143 European Quality of Life Five Dimension (EQ-5D) Utility Values for Clinical Health States in Fabry Disease (FD): Insights from Pegunigalsidase Alpha Clinical Trials
|
Azimpour, K.
|
|
|
26 |
12S |
p. S476
|
artikel
|
| 2040 |
PCR152 Exploring Which Proxy Conditions Are Conceptually Similar to Alopecia Areata, in Terms of Patients Lived Experience and Health-Related Quality of Life: A Scoping Review to Inform HTA Submission
|
Elgares, M.
|
|
|
26 |
12S |
p. S478
|
artikel
|
| 2041 |
PCR28 Facilitating and Accelerating Patient-Centered Outcomes Measures Awareness and Use in Clinical Research in Rare Diseases
|
Desvignes-Gleizes, C.
|
|
|
26 |
12S |
p. S453-S454
|
artikel
|
| 2042 |
PCR85 Facilitating the Identification of Appropriate Patient-Centered Outcome Measures (PCOMS) in Rare Disease (RD) Clinical Research Using Functional Impacts Matching
|
Barbier, V.
|
|
|
26 |
12S |
p. S465
|
artikel
|
| 2043 |
PCR130 Factors Associated With Adjuvant Treatment Options in Resected Stage III Melanoma, From a Patient and Physician Perspective: Preference Assessment Using the Discrete Choice Experiment Method (Pamela Study)
|
Grob, J.J.
|
|
|
26 |
12S |
p. S474
|
artikel
|
| 2044 |
PCR196 Factors Associated with Behaviors Measured By the Rett Syndrome Behavior Questionnaire in Rett Syndrome
|
Downs, J.
|
|
|
26 |
12S |
p. S486-S487
|
artikel
|
| 2045 |
PCR70 Factors Associated with Taking Preventive Migraine Medicines: Results from Overcome (EU) Study
|
Novick, D.
|
|
|
26 |
12S |
p. S462
|
artikel
|
| 2046 |
PCR164 Feasibility and Validation of the Japanese Version of the EQ-HWB
|
Noto, S.
|
|
|
26 |
12S |
p. S480
|
artikel
|
| 2047 |
PCR83 Fibrodysplasia Ossificans Progressiva (FOP): The Patient Experience
|
Shields, A.
|
|
|
26 |
12S |
p. S465
|
artikel
|
| 2048 |
PCR5 First Interim Analysis of Patient-Reported Outcomes in View Study: A Multicenter, Single-Arm, Prospective, Non-Interventional Study of Vonoprazan in Real-World Clinical Practice in China
|
Xiao, Y.
|
|
|
26 |
12S |
p. S448-S449
|
artikel
|
| 2049 |
PCR76 Generating Health-State Utility Values in Patients Treated with Second-Line Systemic Therapy for Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)
|
Soare, I.A.
|
|
|
26 |
12S |
p. S463
|
artikel
|
| 2050 |
PCR95 Healthcare Resource Utilization for Adults Diagnosed with Moderate to Severe Atopic Dermatitis in Greece (APOLO STUDY)
|
Stratigos, A.
|
|
|
26 |
12S |
p. S467
|
artikel
|
| 2051 |
PCR226 Health Related Quality of Life and Health Utility Values Across Different Levels of Physically Distancing Behaviors to Avoid COVID-19 in Immunocompromised Adults – The Eagle Study
|
Lloyd, A.
|
|
|
26 |
12S |
p. S492
|
artikel
|
| 2052 |
PCR35 Health-Related Quality of Life and Its Drivers for Patients Living With Cystic Fibrosis in Five Key European Countries: A Systematic Review
|
Verma, R.
|
|
|
26 |
12S |
p. S455
|
artikel
|
| 2053 |
PCR189 Health-Related Quality of Life and Its Drivers for Patients Living With Glioblastoma in Europe: A Systematic Review
|
Telukuntla, V.
|
|
|
26 |
12S |
p. S485
|
artikel
|
| 2054 |
PCR115 Health-Related Quality of Life Associated With Common Stoma Complications—Peristomal Skin Complications and Leakages Onto Clothes
|
Scheffel, G.
|
|
|
26 |
12S |
p. S471
|
artikel
|
| 2055 |
PCR151 Health Related Quality of Life (HRQOL) Among Patients with Transthyretin Amyloidosis (ATTR): A Systematic Literature Review
|
Delgado, D.
|
|
|
26 |
12S |
p. S477-S478
|
artikel
|
| 2056 |
PCR48 Health-Related Quality of Life in Children with Pneumococcal Disease: What Can We Learn from Cost-Effectiveness Analyses of Pneumococcal Vaccines?
|
Huang, M.
|
|
|
26 |
12S |
p. S458
|
artikel
|
| 2057 |
PCR63 Health-Related Quality of Life in COVID-19: A Vignette Study
|
Ntais, D.
|
|
|
26 |
12S |
p. S461
|
artikel
|
| 2058 |
PCR181 Health-Related Quality-of-Life of Patients Treated with Repotrectinib for Neurotrophic Tyrosine Receptor Kinase (NTRK)-Positive Advanced Solid Tumors: Results from TRIDENT-1
|
Sherif, B.
|
|
|
26 |
12S |
p. S484
|
artikel
|
| 2059 |
PCR267 Health-Related Utilities Associated with Pneumococcal Disease in the Adult Population: What Do We Know?
|
Huang, M.
|
|
|
26 |
12S |
p. S501
|
artikel
|
| 2060 |
PCR193 Health State Utilities Associated with X-Linked Retinitis Pigmentosa in the United Kingdom
|
Matza, L.S.
|
|
|
26 |
12S |
p. S486
|
artikel
|
| 2061 |
PCR82 Hierarchical Clustering of Rare Diseases Based on Functional Impacts to Support the Identification of Potential Patient-Centered Outcomes Measures for Rare Diseases Research
|
Vilcot, T.
|
|
|
26 |
12S |
p. S464-S465
|
artikel
|
| 2062 |
PCR154 How and Why Do Multimorbid Patients Adhere to Their Medications? A Qualitative Study Looking Beyond the Risk-Benefit Scale
|
Artignan, J.
|
|
|
26 |
12S |
p. S478
|
artikel
|
| 2063 |
PCR107 (How) Should Cost-Effectiveness Analysis Accommodate Heterogeneity in Patient Preferences?
|
Hawkins, N.
|
|
|
26 |
12S |
p. S469
|
artikel
|
| 2064 |
PCR72 How to Achieve Comprehensive Care for Breast Cancer? Challenges in Chile from the Voice of Patients
|
Campaña Castillo, C.
|
|
|
26 |
12S |
p. S462
|
artikel
|
| 2065 |
PCR11 Humanistic and Economic Burden of Multiple System Atrophy: A Systematic Review
|
Aggarwal, P.
|
|
|
26 |
12S |
p. S450
|
artikel
|
| 2066 |
PCR18 Humanistic Burden in Relapsed or Refractory (R/R) Follicular Lymphoma (FL): A Systematic Literature Review (SLR)
|
Forbes, C.
|
|
|
26 |
12S |
p. S451-S452
|
artikel
|
| 2067 |
PCR42 Humanistic Burden of Paroxysmal Nocturnal Hemoglobinuria from the Patient Perspective: Results from a Cross-Sectional Study
|
Panse, J.
|
|
|
26 |
12S |
p. S456
|
artikel
|
| 2068 |
PCR219 Hungarian Population Norms for the 15D Generic Preference-Accompanied Health Status Measure
|
Nikl, A.
|
|
|
26 |
12S |
p. S491
|
artikel
|
| 2069 |
PCR90 Hypoglossal Nerve Stimulation (HGNS) for Obstructive Sleep Apnea (OSA): A Systematic Review and Meta-Analysis of Patient-Reported Outcomes
|
Wollny, M.
|
|
|
26 |
12S |
p. S466
|
artikel
|
| 2070 |
PCR173 Identifying Behaviors Practiced By Individuals to Avoid COVID-19: Development of the Content of the Physical Distancing Scale – COVID-19 (PDS-C19)
|
Powell, P.
|
|
|
26 |
12S |
p. S482
|
artikel
|
| 2071 |
PCR178 Illness-Related Uncertainty in Relapsing-Remitting Multiple Sclerosis: Psychometric Properties of the MUIS Questionnaire
|
Ballesteros, J.
|
|
|
26 |
12S |
p. S483
|
artikel
|
| 2072 |
PCR15 Impact of Amyotrophic Lateral Sclerosis on Work and Daily Living: Results from a Real-World Survey
|
Stenson, K.
|
|
|
26 |
12S |
p. S451
|
artikel
|
| 2073 |
PCR4 Impact of Obesity on Health-Related Quality of Life, Sleep, and Work – a Multinational Survey
|
Khare, S.
|
|
|
26 |
12S |
p. S448
|
artikel
|
| 2074 |
PCR144 Impact of Oral Corticosteroid Use on Health-Related Quality of Life: Analysis of EQ-5D Data from Navigator
|
Gibson, D.
|
|
|
26 |
12S |
p. S477
|
artikel
|
| 2075 |
PCR97 Impact of Paroxysmal Nocturnal Haemoglobinuria on Employment and Activity: Results from a Real-World Study
|
Panse, J.
|
|
|
26 |
12S |
p. S468
|
artikel
|
| 2076 |
PCR6 Impact of Perianal Fistulas on Crohn’s Disease Patients
|
Sampaio, A.
|
|
|
26 |
12S |
p. S449
|
artikel
|
| 2077 |
PCR204 Impact of Roflumilast Foam 0.3% on Patient-Reported Quality of Life in Seborrheic Dermatitis: An Analysis of Stratum Data for Patients Unresponsive or Intolerant to Topical Corticosteroids
|
Chu, D.H.
|
|
|
26 |
12S |
p. S488
|
artikel
|
| 2078 |
PCR264 Impact of Sodium Glucose Cotransporter-2 Inhibitors (SGLT2is) on Health-Related Quality of Life (HRQoL) Outcomes in Adult Patients With Type 2 Diabetes Mellitus (T2DM)
|
Kaur, G.
|
|
|
26 |
12S |
p. S500
|
artikel
|
| 2079 |
PCR240 Incorporating a Holistic Patient Perspective When Assessing the Value of Non-Small Cell Lung Cancer (NSCLC) Therapies
|
Damera, V.
|
|
|
26 |
12S |
p. S495-S496
|
artikel
|
| 2080 |
PCR260 Influence of Disease Activity and Angioedema on EQ-5D-5L Utility Scores in Chronic Spontaneous Urticaria
|
Hawe, E.
|
|
|
26 |
12S |
p. S500
|
artikel
|
| 2081 |
PCR121 Insights, Needs, and Perspectives From Patients, Caregivers, and Healthcare Professionals on Shared Decision Making in Duchenne Muscular Dystrophy: A Qualitative Study
|
Schoefs, E.
|
|
|
26 |
12S |
p. S472
|
artikel
|
| 2082 |
PCR104 Is It Worth the Risk? Challenges and Recommendations for Devising Attributes and Levels for Safety-Related Attributes in Patient Preference Studies
|
Mason, B.
|
|
|
26 |
12S |
p. S469
|
artikel
|
| 2083 |
PCR247 Is the Symptomatology of Infantile Tay-Sachs and Infantile Sandhoff Disease Identical? Data from an International Registry
|
Brignoli, L.
|
|
|
26 |
12S |
p. S497
|
artikel
|
| 2084 |
PCR56 Is Walking As Important As Muscle Strength After Stroke? Preference Weighting of ICF's Core Elements
|
Juhnke, C.
|
|
|
26 |
12S |
p. S459
|
artikel
|
| 2085 |
PCR54 Knowledge, Attitudes and Practices of Patients Towards Generics in Greece
|
Souliotis, K.
|
|
|
26 |
12S |
p. S459
|
artikel
|
| 2086 |
PCR134 Listening and Learning from the Voices of Patients with Myelodysplastic Syndromes and Their Caregivers: A Comprehensive Social Media Analysis Using Machine Learning and Natural Language Processing-Based Algorithms
|
Marwah, R.
|
|
|
26 |
12S |
p. S474-S475
|
artikel
|
| 2087 |
PCR96 Long Term Consequences of COVID-19 in Quality of Life in Patients Discharged From Hospital: Systematic Review
|
Casas, C.
|
|
|
26 |
12S |
p. S467
|
artikel
|
| 2088 |
PCR140 Management of Osteogenesis Imperfecta: Self-Reported Access Challenges to Consumables and Services Across the EU5 and Nordics
|
van Welzenis, T.
|
|
|
26 |
12S |
p. S476
|
artikel
|
| 2089 |
PCR250 Management of Osteogenesis Imperfecta: Self-Reported Funding Sources for Healthcare, Consumables and Services Across the EU5 and Nordics
|
Wekre, L.L.
|
|
|
26 |
12S |
p. S497-S498
|
artikel
|
| 2090 |
PCR248 Meaningful Within-Patient Change Threshold Range for the FACIT-Fatigue in Paroxysmal Nocturnal Hemoglobinuria (PNH)
|
Bermann, G.
|
|
|
26 |
12S |
p. S497
|
artikel
|
| 2091 |
PCR238 Measuring the Socioeconomic Impact of Cancer: A Systematic Review and Quality Appraisal of Patient-Reported Outcome (PRO) Instruments
|
Pham, P.D.
|
|
|
26 |
12S |
p. S495
|
artikel
|
| 2092 |
PCR246 Measuring Treatment Preferences for Patients with Pulmonary Arterial Hypertension (PAH); A Discrete Choice Analysis to Identify Scale Heterogeneity
|
Muehlbacher, A.
|
|
|
26 |
12S |
p. S497
|
artikel
|
| 2093 |
PCR106 Merging Adolescent and Adult Preference Data Into a Potential Latent Scale EQ-5D-Y-3L Value Set: A Latent Class Approach to Analyze Contribution of Each Group to the Preference Weights
|
Nazari, J.
|
|
|
26 |
12S |
p. S469
|
artikel
|
| 2094 |
PCR163 Modification of the Social Ecological Model to Distinguish the Terms “HRQoL” and “QoL” in Patient-Centered Outcomes Research
|
Chatterton, K.
|
|
|
26 |
12S |
p. S480
|
artikel
|
| 2095 |
PCR127 Needs and Experiences of Patients and Healthcare Professionals Towards Shared Decision Making in Multiple Myeloma Clinical Practice: A Qualitative Study in Europe
|
Schoefs, E.
|
|
|
26 |
12S |
p. S473
|
artikel
|
| 2096 |
PCR208 Pace CKD Financial Burden and Work Productivity Assessment of Chronic Kidney Disease on Patients: Results from an International Survey
|
Garcia Sanchez, J.J.
|
|
|
26 |
12S |
p. S489
|
artikel
|
| 2097 |
PCR153 Pace CKD: The Impact of Chronic Kidney Disease and Dialysis on Caregivers Financial Status, and Work Productivity: Results from a Multinational Survey
|
Garcia Sanchez, J.J.
|
|
|
26 |
12S |
p. S478
|
artikel
|
| 2098 |
PCR24 Patient and Caregiver Perceptions of Systemic Anticancer Treatments in Advanced Bladder Cancer (aBC): Results of a Social Media Listening (SML) Study Conducted in 5 European Countries (Eu5)
|
Schück, S.
|
|
|
26 |
12S |
p. S453
|
artikel
|
| 2099 |
PCR109 Patient Associations’ Members’ Perceptions of Level and Importance of Participation in Health Technology Assessment in Greece
|
Souliotis, K.
|
|
|
26 |
12S |
p. S469-S470
|
artikel
|
| 2100 |
PCR51 Patient-Centered Instrument Design: Problems and Solutions Based on Patient Feedback
|
Poepsel, T.
|
|
|
26 |
12S |
p. S458
|
artikel
|
| 2101 |
PCR101 Patient-Centric-Approach and Personalized Clinical Trials to Increase Patients Participation in Drug Development: Insight from a Targeted Literature Review (TLR)
|
Collet, J.P.
|
|
|
26 |
12S |
p. S468
|
artikel
|
| 2102 |
PCR74 Patient-Centricity in Haemato-Oncology and Oncology Clinical Trials – A Systematic Literature Review on FDA-Approved Treatments From January 2020 to June 2023
|
Singh, N.
|
|
|
26 |
12S |
p. S463
|
artikel
|
| 2103 |
PCR274 Patient Data Use in Medical Research Vs Data Privacy: Perspective from Five Patient Association Representatives
|
Agush, S.
|
|
|
26 |
12S |
p. S502
|
artikel
|
| 2104 |
PCR216 Patient-Driven Outcome Selection (PDOS): A Patient-Focused Approach for Selecting Outcomes Using Patient-Generated Data
|
Radoszycki, L.
|
|
|
26 |
12S |
p. S491
|
artikel
|
| 2105 |
PCR186 Patient Engagement in Real-World Data Collection: User Characteristics of a Health App for People Living With Pancreatic Cancer
|
Ferguson-Gow, H.
|
|
|
26 |
12S |
p. S485
|
artikel
|
| 2106 |
PCR133 Patient Experience of Second-Line Treatment for Relapsed/Refractory Chronic Lymphocytic Leukaemia in UK Clinical Practice: Study Methodology
|
El-Sharkawi, D.
|
|
|
26 |
12S |
p. S474
|
artikel
|
| 2107 |
PCR32 Patient Preference for Paroxysmal Nocturnal Haemoglobinuria Treatments: Analysis From the Q-Methodology of Treatment Attributes
|
Fishman, J.
|
|
|
26 |
12S |
p. S454
|
artikel
|
| 2108 |
PCR21 Patient Preferences and Expectations Regarding Leukemia and Lymphoma Treatment: Improving Patient Engagement in Portugal through Quantitative and Qualitative Findings
|
Dimitrovova, K.
|
|
|
26 |
12S |
p. S452
|
artikel
|
| 2109 |
PCR80 Patient Preferences for Stages II/III and Stage IV Melanoma Treatments in the UK
|
Vaz, L.
|
|
|
26 |
12S |
p. S464
|
artikel
|
| 2110 |
PCR23 Patient Preferences for Treatment Attributes and Endpoints in Neoadjuvant Therapy for Early-Stage Breast Cancer
|
Batchelder, L.
|
|
|
26 |
12S |
p. S452-S453
|
artikel
|
| 2111 |
PCR182 Patient Preferences for Tumor-Agnostic Therapies: Qualitative Insights and Challenges
|
Metekohy, C.
|
|
|
26 |
12S |
p. S484
|
artikel
|
| 2112 |
PCR259 Patient-Reported Experience Along the Psoriatic Disease Patient Journey in Portugal
|
Dias, A.
|
|
|
26 |
12S |
p. S499-S500
|
artikel
|
| 2113 |
PCR187 Patient-Reported Outcomes in Phase III Randomized Controlled Trials Evaluating First-Line Treatments in Advance/Metastatic Renal Cell Carcinoma: A Systematic Literature Review
|
Rai, P.
|
|
|
26 |
12S |
p. S485
|
artikel
|
| 2114 |
PCR2 Patients’ and Healthcare Professionals’ Preferences Regarding Lipid-Lowering Therapies for Patients with Very High Cardiovascular Risk and Established Atherosclerotic Cardiovascular Disease
|
Parrondo García, F.J.
|
|
|
26 |
12S |
p. S448
|
artikel
|
| 2115 |
PCR91 Patients’ Needs in Assessing Long COVID: A Review of Relevant Concepts and Patient-Reported Outcomes
|
Kraft, N.
|
|
|
26 |
12S |
p. S466-S467
|
artikel
|
| 2116 |
PCR214 Patient Voice in Pharmaceutical Company: The Case of Patient Committee in Brazil
|
Julian, G.
|
|
|
26 |
12S |
p. S490
|
artikel
|
| 2117 |
PCR195 Patient Voice in Smc Technology Appraisals for Orphan and Ultra-Orphan Diseases
|
Gupta, A.
|
|
|
26 |
12S |
p. S486
|
artikel
|
| 2118 |
PCR7 People Living With HIV’s Lived Experiences of Long-Acting Injectable Antiretroviral Treatment Administrations in France Show the Central Role of Hospital Nurses in Care: A Qualitative Study (PANTER)
|
Roucoux, G.
|
|
|
26 |
12S |
p. S449
|
artikel
|
| 2119 |
PCR8 Perceived Barriers to HIV Prevention and Detection Among Adolescents and Young People, According to Civil Organization Leaders and Health Professionals in Chile
|
Chandia, S.
|
|
|
26 |
12S |
p. S449
|
artikel
|
| 2120 |
PCR273 Perceptions, Attitudes, and Satisfaction with Private Pharmacies in Greece: Results from a Nationwide Survey
|
Souliotis, K.
|
|
|
26 |
12S |
p. S502
|
artikel
|
| 2121 |
PCR167 Persistence and Adherence to Insulin Treatment in Chinese Patients with Type 2 Diabetes: A Real-World Study
|
Wen, S.
|
|
|
26 |
12S |
p. S480-S481
|
artikel
|
| 2122 |
PCR172 Physical Distancing to Avoid COVID-19 and the Association With Humanistic Burden in Immunocompromised Adults – The Eagle Study
|
Powell, P.A.
|
|
|
26 |
12S |
p. S482
|
artikel
|
| 2123 |
PCR108 Pilot Testing the Hungarian Version of Online Elicitation of Personal Utility Functions Tool for Valuing EQ-5D-5L Health States
|
Brodszky, V.
|
|
|
26 |
12S |
p. S469
|
artikel
|
| 2124 |
PCR161 Population Norms for the SF-36 Health Status Measure in Hungary
|
Bató, A.
|
|
|
26 |
12S |
p. S479
|
artikel
|
| 2125 |
PCR89 Predicting EQ-5D-5L Score by Using SGRQ in Patients with Asthma and/or COPD in NOVELTY
|
Jackson, D.
|
|
|
26 |
12S |
p. S466
|
artikel
|
| 2126 |
PCR20 Preferences for Cancer Treatments: A Discrete-Choice Experiment with Adult Patients with Cancer in Europe
|
Botha, W.
|
|
|
26 |
12S |
p. S452
|
artikel
|
| 2127 |
PCR169 Prevalence and Predictive Factors of Psychological Distress Among People with Diabetes in France
|
Cerletti, P.
|
|
|
26 |
12S |
p. S481
|
artikel
|
| 2128 |
PCR14 Prioritization of Social Disability Management Using a Patient Reported Outcome Questionnaire in Patients Suffering from Multiple Sclerosis (MS)
|
Donze, C.
|
|
|
26 |
12S |
p. S450-S451
|
artikel
|
| 2129 |
PCR29 Progressive Disease Milestones and Survival in Duchenne Muscular Dystrophy (DMD): A Model-Based Synthesis for Extrapolating Lifetime Treatment Effects From Clinical Trial Results
|
Smith, E.
|
|
|
26 |
12S |
p. S454
|
artikel
|
| 2130 |
PCR122 Psychometric Evaluation of Multiple Sclerosis Impact Scale 29 Version 2 in Relapsing Multiple Sclerosis Patients Participating in a Phase 2 Study of Frexalimab
|
Giovannoni, G.
|
|
|
26 |
12S |
p. S472
|
artikel
|
| 2131 |
PCR31 Psychometric Performance of the Functional Assessment of Chronic Illness Therapy (FACIT) Fatigue Questionnaire Among Patients With Paroxysmal Nocturnal Hemoglobinuria
|
Cella, D.
|
|
|
26 |
12S |
p. S454
|
artikel
|
| 2132 |
PCR232 Psychometric Properties of a Patient Reported Outcome Measure (PROM) Evaluating Patient Autonomy in Multiple Sclerosis (MS)
|
Mekies, C.
|
|
|
26 |
12S |
p. S494
|
artikel
|
| 2133 |
PCR66 Psychometric Validation of PROMIS-Fatigue-MS-8a Questionnaire in Relapsing Multiple Sclerosis Patients Participating in a Phase 2 Study of Frexalimab
|
Vermersch, P.
|
|
|
26 |
12S |
p. S461
|
artikel
|
| 2134 |
PCR243 Psychometric Validation of QlQ-OES18 in 2L Esophageal Squamous Cell Cancer (ESCC) Patients Treated with Tislelizumab Versus Chemotherapy
|
Podger, L.
|
|
|
26 |
12S |
p. S496
|
artikel
|
| 2135 |
PCR124 Qualitative Exploration of the Patient Experience of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Via Concept Elicitation Interviews with Patients and Neurologists
|
Roberts, A.
|
|
|
26 |
12S |
p. S473
|
artikel
|
| 2136 |
PCR272 Qualitative Research to Explore Womens Experience of Vasomotor Symptoms and Evaluate the Suitability of Patient-Reported Outcomes
|
Haberland, C.
|
|
|
26 |
12S |
p. S502
|
artikel
|
| 2137 |
PCR197 Quality of Life and Duchenne Muscular Dystrophy: Greek Translation of the Pediatric Quality of Life Inventory (PEDSQL)3.0 Duchenne Muscular Dystrophy Module
|
Katsomiti, E.
|
|
|
26 |
12S |
p. S487
|
artikel
|
| 2138 |
PCR249 Quality of Life of Moroccan Children with Rare Diseases: Evidence from Real-World Data
|
El Hani, M.
|
|
|
26 |
12S |
p. S497
|
artikel
|
| 2139 |
PCR239 Quality of Life (QOL) Instruments Used in Clinicaltrials.gov-Indexed Trials of Gene-Modified Cell Therapy (GMCT) in Patients With Multiple Myeloma (MM)
|
Cadarette, S.
|
|
|
26 |
12S |
p. S495
|
artikel
|
| 2140 |
PCR221 Real-World Adherence to Anti-PCSK9 Monoclonal Antibody (mAb) and Its Impact on Economic Burden of Cardiovascular Diseases in Patients with Hypercholesterolemia: A Retrospective Cohort Study in China
|
Xiao, F.
|
|
|
26 |
12S |
p. S491
|
artikel
|
| 2141 |
PCR230 Real-World Clinical Characteristics of Patients with Migraine Who Initiated Fremanezumab in Sweden: An Observational, Nationwide Register-Based Study
|
Linde, M.
|
|
|
26 |
12S |
p. S493
|
artikel
|
| 2142 |
PCR75 Real-World Evidence of Outcomes of Fulvestrant Monotherapy After Progression on CDK4/6 Inhibitor + Aromatase Inhibitor in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
|
Nur, U.
|
|
|
26 |
12S |
p. S463
|
artikel
|
| 2143 |
PCR175 Real-World Impact of Migraine on Canadians’ Productivity: A Pharmacy-Based Study
|
Patenaude, J.
|
|
|
26 |
12S |
p. S482-S483
|
artikel
|
| 2144 |
PCR98 Reduced Dialysis Adherence and Greater Medication Use Associated with Increased Itch Severity
|
Ion Titapiccolo, J.
|
|
|
26 |
12S |
p. S468
|
artikel
|
| 2145 |
PCR166 Regaining Activities of Daily Living After Stroke – What Matters Most for Patients in Neurorehabilitation?
|
Juhnke, C.
|
|
|
26 |
12S |
p. S480
|
artikel
|
| 2146 |
PCR9 Rise of Undiagnosed Major Depressive Disorder Post-COVID-19 Pandemic in Europe
|
Annunziata, K.
|
|
|
26 |
12S |
p. S449-S450
|
artikel
|
| 2147 |
PCR222 Safety and Quality of Life of Various Artificial Pancreas Systems in Patients With Type 1 Diabetes Mellitus: A Systematic Review of Real-World Evidence
|
Kaushik, P.
|
|
|
26 |
12S |
p. S491
|
artikel
|
| 2148 |
PCR135 Selecting Preference-Based Measures (PBMS) for Pediatric Studies: A Proposed Decision Making Framework
|
Sutherland, C.S.
|
|
|
26 |
12S |
p. S475
|
artikel
|
| 2149 |
PCR59 Self-Reported Health Status and Its Predictors Among People with Diabetes in France
|
Arnaut, T.
|
|
|
26 |
12S |
p. S460
|
artikel
|
| 2150 |
PCR73 Sensitivity of EQ-5D to Assess Health-Related Quality of Life (HRQoL) for Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM): KarMMa-3 Case Study Exploring EQ-5D Mapped from Disease-Specific Instruments
|
Paul, E.
|
|
|
26 |
12S |
p. S463
|
artikel
|
| 2151 |
PCR60 Shared Decision Making in Inflammatory Bowel Disease Clinical Practice: What Are the Experiences, Barriers, and Opportunities According to Patients and Healthcare Professionals?
|
Schoefs, E.
|
|
|
26 |
12S |
p. S460
|
artikel
|
| 2152 |
PCR198 Should We be Mapping from Sleep-Specific to Generic Preference-Based Quality-of-Life Instruments? Unravelling the Debate with a Multi-Instrument Mapping Study of 6 Sleep-Specific and 4 Preference-Based Instruments
|
Kaambwa, B.
|
|
|
26 |
12S |
p. S487
|
artikel
|
| 2153 |
PCR58 Social Media Research to Understand Reported Efficacy of GLP-1 RAs for Weight Loss
|
Mohan, M.
|
|
|
26 |
12S |
p. S460
|
artikel
|
| 2154 |
PCR233 Socioeconomic Impact of Muscular Dystrophies on Patients and Their Caregivers in the Czech Republic
|
Volfova, G.
|
|
|
26 |
12S |
p. S494
|
artikel
|
| 2155 |
PCR22 Solidifying Usability Testing Guidelines for Ecoas From the Patient Perspective
|
Hadjidemetriou, C.
|
|
|
26 |
12S |
p. S452
|
artikel
|
| 2156 |
PCR245 Stakeholder Engagement and Expert Consultation on the EuroQol Toddler and Infant Populations (EQ-TIPS) Measure of Health-Related Quality of Life (HRQoL)
|
Verstraete, J.
|
|
|
26 |
12S |
p. S496-S497
|
artikel
|
| 2157 |
PCR77 Symptom Burden and Health-Related Quality of Life (HRQoL) in Gastrointestinal (GI) Cancers: A Targeted Literature Review
|
Chung, K.C.
|
|
|
26 |
12S |
p. S463-S464
|
artikel
|
| 2158 |
PCR162 Talking with Teens: Techniques for Building Rapport with Adolescents in Virtual Qualitative Interviews
|
Lowe, C.
|
|
|
26 |
12S |
p. S479-S480
|
artikel
|
| 2159 |
PCR26 Testing the Psychometric Properties of Several Euroqol Instruments for Measuring the Impact of COVID-19 in a Large Sample of Chinese Children and Their Parent Carers
|
Zhou, W.
|
|
|
26 |
12S |
p. S453
|
artikel
|
| 2160 |
PCR225 The Added Value of the Cognition, Dining, Gastrointestinal Problems, Sleep, and Tiredness Bolt-Ons for the EQ-5D-5L in Patients With Coeliac Disease
|
Angyal, M.
|
|
|
26 |
12S |
p. S492
|
artikel
|
| 2161 |
PCR50 The Adelphi Adherence Questionnaire (ADAQ©): Psychometric Validation of a New Patient Self-Report Measure of Medication Adherence Across Multiple Disease Areas
|
Clarke, N.
|
|
|
26 |
12S |
p. S458
|
artikel
|
| 2162 |
PCR33 The Application of Stated Preference Methods in Rare Disease: A Systematic Review
|
Hall, R.
|
|
|
26 |
12S |
p. S455
|
artikel
|
| 2163 |
PCR114 The Association Between Health-Related Quality of Life and Social Determinants of Health for Diabetes in Japan: A Cross-Sectional Patient Survey
|
Murofushi, T.
|
|
|
26 |
12S |
p. S470-S471
|
artikel
|
| 2164 |
PCR13 The Burden of Informal Caregivers of People Diagnosed With Myasthenia Gravis
|
Dewilde, S.
|
|
|
26 |
12S |
p. S450
|
artikel
|
| 2165 |
PCR234 The Burden of Migraine in Czech Republic: Patient, Payer, and Societal Perspective
|
Doleckova, K.
|
|
|
26 |
12S |
p. S494
|
artikel
|
| 2166 |
PCR253 The Burden of Persistent Cough in Idiopathic Pulmonary Fibrosis (IPF) and Other Interstitial Lung Diseases (ILD): A Systematic Evidence Synthesis
|
Green, R.
|
|
|
26 |
12S |
p. S498
|
artikel
|
| 2167 |
PCR136 The Burden of Systemic Mastocytosis in Select European Countries: Evidence from the Prism Patient Survey
|
Mesa, R.
|
|
|
26 |
12S |
p. S475
|
artikel
|
| 2168 |
PCR119 The CaOa-QoL-TS: Development and Validation of an Owner-Completed Health-Related Quality of Life and Treatment Satisfaction Measure in Canine Osteoarthritis
|
Gildea, E.
|
|
|
26 |
12S |
p. S471-S472
|
artikel
|
| 2169 |
PCR46 The Current Usage and Challenges of Goal Attainment Scaling in Clinical Settings
|
Nesto, S.
|
|
|
26 |
12S |
p. S457
|
artikel
|
| 2170 |
PCR84 The Daily Life and Psychosocial Impacts of Friedreich Ataxia: A Qualitative Study of Patient Lived Experiences
|
Bever, A.
|
|
|
26 |
12S |
p. S465
|
artikel
|
| 2171 |
PCR17 The Development of a Comprehensive Archive of Patient-Reported Outcome Measures (PROMS) for Clinical Research and Clinical Practice in Oncology
|
Malandrini, F.B.
|
|
|
26 |
12S |
p. S451
|
artikel
|
| 2172 |
PCR19 The EU Patient Community's Perspectives on Data Protection and Data Control
|
Lalova-Spinks, T.
|
|
|
26 |
12S |
p. S452
|
artikel
|
| 2173 |
PCR92 The Experience and Utilization of Patient Reported Outcomes (PROs) in Leber’s Hereditary Optic Neuropathy (LHON): A Targeted Literature Review
|
Mumford, A.
|
|
|
26 |
12S |
p. S467
|
artikel
|
| 2174 |
PCR241 The Experience of Patients Living with Multiple Myeloma: Unmet Needs Associated with Diagnosis, Treatment, and Living with the Condition
|
Morgan, K.
|
|
|
26 |
12S |
p. S496
|
artikel
|
| 2175 |
PCR34 The Humanistic and Economic Burden of Illness in Progressive Fibrosing Idiopathic Lung Disease: A Targeted Literature Review
|
Jozsa, I.G.
|
|
|
26 |
12S |
p. S455
|
artikel
|
| 2176 |
PCR141 The Impact of Duchenne Muscular Dystrophy on Caregiver Employment: A Survey in Europe, Japan, and the United States
|
Strober, J.
|
|
|
26 |
12S |
p. S476
|
artikel
|
| 2177 |
PCR37 The Impact of Leber’s Heredity Optic Neuropathy (LHON) on Quality of Life (QoL): A Systematic Literature Review (SLR)
|
Mumford, A.
|
|
|
26 |
12S |
p. S455-S456
|
artikel
|
| 2178 |
PCR41 The Impact of Moderate to Severe Chronic Hand Eczema and the Effect of Improved Clinical Symptoms on Work Productivity Loss: Data from the DELTA 1 and DELTA 2 Phase 3 Trials
|
Bauer, A.
|
|
|
26 |
12S |
p. S456
|
artikel
|
| 2179 |
PCR180 The Life with Myasthenia Gravis: Socioeconomic Impact of the Disease on Patients in the Czech Republic
|
Danielisova, M.
|
|
|
26 |
12S |
p. S484
|
artikel
|
| 2180 |
PCR174 The Patient-Centered Core Impact Set Taxonomy: A Practical Example of Use and Refinement Using Voice-of-the-Patient Reports and Patient Interviews
|
Majercak, K.
|
|
|
26 |
12S |
p. S482
|
artikel
|
| 2181 |
PCR170 The Prevalence and Factors That Affect Perceived Stress, Anxiety, and Depression Among IBD Patients
|
Kaur, K.
|
|
|
26 |
12S |
p. S481
|
artikel
|
| 2182 |
PCR179 The Socio-Economic and Health-Related Quality of Life Impact of Myasthenia Gravis (MG) in Greece
|
Aggelina, A.
|
|
|
26 |
12S |
p. S483-S484
|
artikel
|
| 2183 |
PCR231 The Socio-Economic Burden on Caregivers of Pediatric Autistic Population in Europe: A Systematic Review
|
Johri, S.
|
|
|
26 |
12S |
p. S494
|
artikel
|
| 2184 |
PCR158 The Uniqueness and Overlap of the EQ-HWB and the EQ-5D-5L in Four Diseases, Healthy Subjects, and Caregivers
|
Zhang, G.
|
|
|
26 |
12S |
p. S479
|
artikel
|
| 2185 |
PCR53 To What Extent European Value-Based Pricing Methodologies Take Into Account Patient Perspectives and Broader Societal Benefits?
|
Vassoler, H.
|
|
|
26 |
12S |
p. S459
|
artikel
|
| 2186 |
PCR171 Translation and Cross-Cultural Validation of the Chinese Version of Adult Social Care Outcomes Toolkit for Service Users in Hong Kong
|
Yu, S.
|
|
|
26 |
12S |
p. S481
|
artikel
|
| 2187 |
PCR110 Translation and Cultural Adaptation of Clinical Outcome Assessments (COAs)—Is Machine Translation a Viable Option?
|
Grijalva, S.G.
|
|
|
26 |
12S |
p. S470
|
artikel
|
| 2188 |
PCR266 Transplant Physicians’ Preferences in Deceased Organ Allocation: A Pilot Discrete Choice Experiment
|
Oedingen, C.
|
|
|
26 |
12S |
p. S501
|
artikel
|
| 2189 |
PCR236 Treatment Preferences Among Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in France, Germany, Italy, Japan, Spain, the United States, and the United Kingdom
|
Michaels-Igbokwe, C.
|
|
|
26 |
12S |
p. S495
|
artikel
|
| 2190 |
PCR62 Treatment Satisfaction and Health-Related Quality of Life in People Living With HIV Receiving DTG/3TC Who Are Treatment Experienced or Treatment Naive in Europe
|
O’Brien, P.
|
|
|
26 |
12S |
p. S460-S461
|
artikel
|
| 2191 |
PCR146 Tuberculosis Patients’ Preferences for Improving Tuberculosis Care in Chitwan District, Nepal: A Discrete Choice Experiment
|
Aryal, T.P.
|
|
|
26 |
12S |
p. S477
|
artikel
|
| 2192 |
PCR261 Uncovering Patient-Reported Outcome Differences Between Undiagnosed and Diagnosed Individuals With Moderate to Severe Psoriasis in Europe
|
Sternbach, N.
|
|
|
26 |
12S |
p. S500
|
artikel
|
| 2193 |
PCR16 Uncovering the Influence of Smoking on Health Care Processes for Adult Lung Cancer Patients in Chile: Insights From a Multi-Perspective Qualitative Study
|
Campaña Castillo, C.
|
|
|
26 |
12S |
p. S451
|
artikel
|
| 2194 |
PCR69 Understanding Determinants of the Burden Experienced by Informal Caregivers of Myasthenia Gravis Patients
|
Dewilde, S.
|
|
|
26 |
12S |
p. S462
|
artikel
|
| 2195 |
PCR137 Understanding the Signs, Symptoms and Impacts of Metachromatic Leukodystrophy (MLD)
|
Patel, C.
|
|
|
26 |
12S |
p. S475
|
artikel
|
| 2196 |
PCR55 Unleashing the Power of Social Media Listening: A Promising Tool for Patient-Focused Research
|
Gautam, R.
|
|
|
26 |
12S |
p. S459
|
artikel
|
| 2197 |
PCR40 Unmet Medical Needs and Treatment Preferences for Systemic Treatments in Patients with Moderate to Severe Psoriasis: A Cross-Sectional Survey Study in China
|
Kuang, Y.
|
|
|
26 |
12S |
p. S456
|
artikel
|
| 2198 |
PCR125 Unmet Needs of People with Multiple Sclerosis: Findings for an Improvement of the Patient Journey in Portugal
|
Dimitrovova, K.
|
|
|
26 |
12S |
p. S473
|
artikel
|
| 2199 |
PCR215 Usability Testing of a Non-Consumer Smartphone Device for ePRO Data Collection
|
Garner, K.
|
|
|
26 |
12S |
p. S490-S491
|
artikel
|
| 2200 |
PCR88 Use of Patient-Reported Outcomes for Sickle-Cell Disease in Clinical Trials – Do They Match with Consensus-Based Core Outcomes Sets Recommendations?
|
Adiutori, R.
|
|
|
26 |
12S |
p. S466
|
artikel
|
| 2201 |
PCR52 Use of Patient Reported Outcomes in Key Trials Supporting Marketing Authorisation: 5-Year Analysis of Company Evidence Submitted for National Institute for Health and Care Excellence (NICE) Single Technology Appraisal (STA)
|
Los, A.
|
|
|
26 |
12S |
p. S458-S459
|
artikel
|
| 2202 |
PCR71 Using Schedule for the Evaluation of Individual Quality of Life (SEIQoL) and Computer Adapted Testing (CAT) in Current Practices
|
Joseph, A.
|
|
|
26 |
12S |
p. S462
|
artikel
|
| 2203 |
PCR103 Validating an Herpes Zoster Health Related Quality of Life Conceptual Model in Argentina: Literature Review and Qualitative Study
|
Belizan, M.
|
|
|
26 |
12S |
p. S468-S469
|
artikel
|
| 2204 |
PCR1 Validity of Preference-Weighted Scores: A Case Study of the International Classification of Functioning, Disability, & Health
|
Juhnke, C.
|
|
|
26 |
12S |
p. S448
|
artikel
|
| 2205 |
PCR199 Value-Based Healthcare in Severe Asthma: Development of an Outcome Standard Set Pilot Study in Portugal
|
Costa, F.
|
|
|
26 |
12S |
p. S487
|
artikel
|
| 2206 |
PCR100 Vascular Access Adverse Events: A Comprehensive Literature Review and Comparative Analysis
|
Bouguerra, H.
|
|
|
26 |
12S |
p. S468
|
artikel
|
| 2207 |
PCR45 Vascular Access Devices: A Comparative Analysis of Complications and Their Cost Implications
|
Bouguerra, H.
|
|
|
26 |
12S |
p. S457
|
artikel
|
| 2208 |
PCR139 'We Have Conversations That Other Couples Don′t Have to Have:' A Qualitative Study of the Impact of Caregiving in Friedreich Ataxia (FA)
|
Szabo, S.
|
|
|
26 |
12S |
p. S476
|
artikel
|
| 2209 |
PCR111 Which Body Functions and Activities Matter for Stroke Patients? Study Protocol for Best–Worst Scalings to Value Core Elements of the ICF
|
Juhnke, C.
|
|
|
26 |
12S |
p. S470
|
artikel
|
| 2210 |
PCR44 Work and Activity Impairment in Individuals With Chronic Kidney Disease According to Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Use
|
Ofori-Asenso, R.
|
|
|
26 |
12S |
p. S457
|
artikel
|
| 2211 |
P19 Demographics of Patients and Societal Burden of Obstructive Hypertrophic Cardiomyopathy: Results From a Real-World Survey in Italy and Spain
|
Lowe, M.
|
|
|
26 |
12S |
p. S5
|
artikel
|
| 2212 |
P53 Description of Polypharmacy and PIM Use Trends in the Elderly From the Perspective of Deprescribing
|
Pan, S.
|
|
|
26 |
12S |
p. S13
|
artikel
|
| 2213 |
P22 Disrupting Health Economics: Automating Network Meta-Analyses With AI and Large Language Models
|
Reason, T.
|
|
|
26 |
12S |
p. S6
|
artikel
|
| 2214 |
P30 Do Novel Oncology Combination Therapies Have a Place Within the EU Legislative Framework? The Impact of Challenges for Novel Combination Therapies on Equality of Access Between European Patients
|
Pistollato, M.
|
|
|
26 |
12S |
p. S8
|
artikel
|
| 2215 |
P46 Drivers of Health Technology Assessment Methods and Process Reforms: An International Comparison of Real World Evidence, Patient Involvement and Discounting
|
Bell, E.
|
|
|
26 |
12S |
p. S11-S12
|
artikel
|
| 2216 |
P26 Drug Utilization, Adherence, and Persistence in Parkinson's Disease Patients in a Real-World Setting in Quebec, Canada
|
Baribeau, V.
|
|
|
26 |
12S |
p. S7
|
artikel
|
| 2217 |
P42 Enhancing the Understanding of Phenotypic Outcomes in Sickle Cell Disease (SCD) Through a Comparison Between Data Collected Through App-Based Home-Reported Outcomes (HROs) Versus Qualitative Methodologies
|
Zhang, C.
|
|
|
26 |
12S |
p. S11
|
artikel
|
| 2218 |
P31 Evidence Supporting Regulatory Withdrawals and Quantifying Their Impact on Public Health
|
Lane, S.
|
|
|
26 |
12S |
p. S8
|
artikel
|
| 2219 |
P23 Evolving Use of Artificial Intelligence and Machine Learning in Systematic Literature Reviews (SLRs)
|
Kamra, S.
|
|
|
26 |
12S |
p. S6
|
artikel
|
| 2220 |
P33 Extending the PICOTS Framework for Evidence Syntheses of Digital Health Interventions: Results of a Delphi Consensus Study
|
Zrubka, Z.
|
|
|
26 |
12S |
p. S8-S9
|
artikel
|
| 2221 |
P38 Forecasting Emergency Department Waiting Times Using Deep Neural Networks
|
Pak, A.
|
|
|
26 |
12S |
p. S10
|
artikel
|
| 2222 |
P34 Health Technology Assessments of Digital Public Health Interventions in the Southeast Asia - A Systematic Scoping Review
|
Gudi, N.
|
|
|
26 |
12S |
p. S9
|
artikel
|
| 2223 |
P47 How Do HTA Agencies Manage Uncertainties in the Long-Term Clinical Benefit of Gene Therapies? An Analysis of Recent Gene Therapy HTAs in England, Germany, France, Italy, Canada, and the United States
|
McCormick, B.
|
|
|
26 |
12S |
p. S12
|
artikel
|
| 2224 |
P35 How Perspective Affects the Cost-Effectiveness of Remote Patient Monitoring for Patients With Heart Failure in Different European Countries
|
Mokri, H.
|
|
|
26 |
12S |
p. S9
|
artikel
|
| 2225 |
P27 How Untruthfulness in Self-Reported Medication Adherence Influences Treatment Preferences: A Discrete Choice Experiment
|
Oedingen, C.
|
|
|
26 |
12S |
p. S7
|
artikel
|
| 2226 |
P9 Impact of Organized Colorectal Cancer Screening on Age-Specific Population Incidences: Evidence from a Natural Experiment in Sweden
|
Chauca Strand, G.
|
|
|
26 |
12S |
p. S2
|
artikel
|
| 2227 |
P10 Impact of the COVID-19 Pandemic on Cancer Screenings in Portugal and Years of Life Lost Due to Delayed Diagnoses
|
Mendes, D.
|
|
|
26 |
12S |
p. S2-S3
|
artikel
|
| 2228 |
P32 Implementation of Early Access Reform in France and Access to Innovation: Impact in Terms of Number of Drugs, Patients Treated, and Cost
|
Martin, T.
|
|
|
26 |
12S |
p. S8
|
artikel
|
| 2229 |
P24 Improving Efficiency of Living Systematic Literature Reviews (SLR) with Artificial Intelligence (AI): Assisted Extraction of Population, Intervention/Comparator, Outcome, and Study Design (P-I/C-O-S)
|
Liu, R.
|
|
|
26 |
12S |
p. S6
|
artikel
|
| 2230 |
P7 International Reference Pricing and Joint Clinical Assessments—How Will European-Level HTA Evaluations Impact International Reference Pricing and Launch Sequencing?
|
Saei, A.
|
|
|
26 |
12S |
p. S2
|
artikel
|
| 2231 |
P50 Joint Modelling of Intermediate Longitudinal Biomarkers to Predict Overall Survival in Patients with Solid Tumors
|
Linsell, L.
|
|
|
26 |
12S |
p. S12-S13
|
artikel
|
| 2232 |
P39 Machine Learning to Identify Atopic Dermatitis Prevalence Using Healthcare Utilisation Patterns of Both Diagnosed and Non-Diagnosed AD Patients Based on Danish Register Data
|
Liljendahl, M.
|
|
|
26 |
12S |
p. S10
|
artikel
|
| 2233 |
P40 Man Versus Machine: Can AI-Assisted Technology be Used to Support the Development of Economic Models?
|
Medland, S.
|
|
|
26 |
12S |
p. S10
|
artikel
|
| 2234 |
P20 Matching-Adjusted Indirect Treatment Comparison (MAIC) of Teclistamab Vs Belantamab Mafodotin for the Treatment of Patients with Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM)
|
Moreau, P.
|
|
|
26 |
12S |
p. S5-S6
|
artikel
|
| 2235 |
P28 Medication Non-Adherence in Patients with Varying Levels of Depression Symptoms Measured Using the Medication Adherence Reasons Scale
|
Unni, E.
|
|
|
26 |
12S |
p. S7
|
artikel
|
| 2236 |
P48 New NICE Proportionate Approaches: Are They Any Faster or More Successful?
|
Andrews, R.
|
|
|
26 |
12S |
p. S12
|
artikel
|
| 2237 |
P2 NICE's Pathways Pilot: Incorporating Disease-Specific Reference Models Into Health Technology Assessment in England
|
Brooke, A.
|
|
|
26 |
12S |
p. S1
|
artikel
|
| 2238 |
P3 Open-Source Model Framework for Health-Economic Evaluation of Early Treatment in Alzheimer's Disease
|
Handels, R.
|
|
|
26 |
12S |
p. S1
|
artikel
|
| 2239 |
P54 Patient-Reported & Health Economic Outcomes for Low-Value Medications in Patients Living with Dementia
|
Platen, M.
|
|
|
26 |
12S |
p. S13-S14
|
artikel
|
| 2240 |
P55 Prevalence and Predictors of Primary Non-Adherence to Medications Prescribed in Primary Care
|
Zeitouny, S.
|
|
|
26 |
12S |
p. S14
|
artikel
|
| 2241 |
P11 Real-World Evidence of Total Colonoscopy for Colorectal Cancer Screening Based on Test Performance RCTs
|
Hamashima, C.
|
|
|
26 |
12S |
p. S3
|
artikel
|
| 2242 |
P12 Screen-Detected Breast Cancers Have Improved 5-Year Disease Free Interval Compared to Interval and Non-Screen-Related Breast Cancer, Taking Lead Time into Account
|
Eijkelboom, A.
|
|
|
26 |
12S |
p. S3
|
artikel
|
| 2243 |
P44 Seeing it in the Flesch: Comparing Readability Between AI-Generated and Human-Written Plain-Language Abstracts
|
McMinn, D.
|
|
|
26 |
12S |
p. S11
|
artikel
|
| 2244 |
PT1 A Comparison of the UK and Australian Interim Value Sets for the Weight-Specific Adolescent Instrument for Economic Evaluation (WAItE)
|
Robinson, T.
|
|
|
26 |
12S |
p. S503
|
artikel
|
| 2245 |
PT19 Analysis of the Access to Medicines for Rare Diseases in Countries from the Balkan Peninsula: A Comparative Analysis
|
Haygarova, I.
|
|
|
26 |
12S |
p. S291-S292
|
artikel
|
| 2246 |
PT13 An Evaluation of the Impact of Evidence Grouping on Certainty Rating When Performing a Grade Assessment Without a Meta-Analysis
|
Cervelo Bouzo, P.
|
|
|
26 |
12S |
p. S425
|
artikel
|
| 2247 |
PT20 Applications for Tolvaptan (JINARC®) Under a Managed Access Protocol in Ireland
|
Kelly, L.
|
|
|
26 |
12S |
p. S292
|
artikel
|
| 2248 |
PT37 A Systematic Review of Modelling Approaches in Economic Evaluations of Treatments for Inherited Bleeding Disorders
|
Prameyllawati, D.
|
|
|
26 |
12S |
p. S201-S202
|
artikel
|
| 2249 |
PT31 A Time Series Analysis of Immune Checkpoint Inhibitors Use in Italian Population: 2017-2022
|
Mucherino, S.
|
|
|
26 |
12S |
p. S540
|
artikel
|
| 2250 |
PT14 Bayesian Meta-Analysis of Data From Trials of Mixed Patient Populations to Inform Health Economic Models for Patients Harboring a Predictive Biomarker
|
Wheaton, L.
|
|
|
26 |
12S |
p. S425
|
artikel
|
| 2251 |
PT38 Budget Impact Analysis of rFVIII Glycopegylated-Exei for the Treatment of Haemophilia A in Colombia
|
Casas-Ramirez, D.
|
|
|
26 |
12S |
p. S202
|
artikel
|
| 2252 |
PT15 Comparing the Impact of Random Forest Vs Bayesian G-Computation on Matching-Adjusted Indirect Comparisons of Treatments Between Trials: A Simulation Study
|
Moradian, H.
|
|
|
26 |
12S |
p. S425
|
artikel
|
| 2253 |
PT2 Comparing UK Value Sets and Mapping Functions for EQ-5D
|
Maervoet, J.
|
|
|
26 |
12S |
p. S503
|
artikel
|
| 2254 |
PT25 Comparison of Approval Dates of New Substances Between the United States of America (Food and Drug Administration, FDA) and Europe (European Medicines Agency, EMA)
|
Batscheider, A.
|
|
|
26 |
12S |
p. S293
|
artikel
|
| 2255 |
PT3 Concept Elicitation Interviews to Refine a Conceptual Model of the Patient Experience of Amyotrophic Lateral Sclerosis (ALS)
|
Al-zubeidi, T.
|
|
|
26 |
12S |
p. S503
|
artikel
|
| 2256 |
PT43 Cost-Effectiveness Analysis of Prostate-Specific Antigen (PSA)-Based Risk-Adapted Screening in Germany: An Early Economic Evaluation Study
|
Muchadeyi, M.
|
|
|
26 |
12S |
p. S202
|
artikel
|
| 2257 |
PT32 Cost-Effectiveness of Lorlatinib in Second-Line Treatment of ALK-Positive Advanced Non-Small Cell Lung Cancer in China
|
Shi, S.
|
|
|
26 |
12S |
p. S201
|
artikel
|
| 2258 |
PT44 Cost-Effectiveness of Olaparib Vs. Rucaparib for Patients with Metastatic Castration-Resistant Prostate Cancer – the Canadian Perspective
|
Yanev, I.
|
|
|
26 |
12S |
p. S202
|
artikel
|
| 2259 |
PT33 Cost-Effectiveness of Pembrolizumab Plus Chemotherapy, With or Without Bevacizumab for the First-Line Treatment of PD-L1-Positive Patients With Persistent, Recurrent, or Metastatic Cervical Cancer in France
|
Ray-Coquard, I.
|
|
|
26 |
12S |
p. S201
|
artikel
|
| 2260 |
PT7 Data Standardization in Brazil: An OMOP Common Data Model Approach in a DATASUS Cohort
|
Oliveira, J.C.B.
|
|
|
26 |
12S |
p. S539
|
artikel
|
| 2261 |
PT45 Disease Relapse and Adverse Events During the Combination Use of Clozapine and Long-Acting Injectable Antipsychotics and During the Clozapine Monotherapy
|
Wei, Y.
|
|
|
26 |
12S |
p. S49
|
artikel
|
| 2262 |
PT46 Does Public Research Investment on Emerging Infectious Diseases Correspond to Disease Burden in China? A Cross-Sectional Study from 2009 to 2019
|
Ma, J.
|
|
|
26 |
12S |
p. S293
|
artikel
|
| 2263 |
PT40 Epidemiology and Burden of Illness of Lupus in Children by Form of Lupus: A Retrospective Longitudinal National Hospital Claims Study in France
|
Cohen, N.
|
|
|
26 |
12S |
p. S558
|
artikel
|
| 2264 |
P51 Testing a Survival Extrapolation Algorithm for Cancer Immunotherapies: Pass or Fail?
|
Latimer, N.
|
|
|
26 |
12S |
p. S13
|
artikel
|
| 2265 |
P4 Testing SimPy, a Library for Patient-Level Simulations in Python: An Application to Resource Management in Healthcare Systems
|
Felizzi, F.
|
|
|
26 |
12S |
p. S1-S2
|
artikel
|
| 2266 |
PT21 Evaluation and Reimbursement of Digital Therapeutics in Germany, France, Belgium and England
|
Tokarska, J.
|
|
|
26 |
12S |
p. S292
|
artikel
|
| 2267 |
PT22 Exploring Reimbursement Disparities: A Comparative Study of Pharmaceutical Access in Hong Kong and Mainland China
|
Wang, Y.
|
|
|
26 |
12S |
p. S292
|
artikel
|
| 2268 |
PT8 Five-Year Healthcare Resource Consumption and Direct Costs of Women with a New Diagnosis of Hr+/HER2- Breast Cancer Primary or Advanced: Analysis of a Large Italian Administrative Database
|
Dell'Anno, I.
|
|
|
26 |
12S |
p. S254
|
artikel
|
| 2269 |
PT9 Harnessing the Potential of Natural-Language Processing and Interconnected Data Streams for Complex Diseases in the Hospital Setting: Lupus Case Study in France (LUPUS REAL)
|
Jouve, M.
|
|
|
26 |
12S |
p. S558
|
artikel
|
| 2270 |
P8 The Dutch Lock Procedure for Reimbursement Works as Intended
|
Boer, J.
|
|
|
26 |
12S |
p. S2
|
artikel
|
| 2271 |
PT47 High-Volume Hospitals Experience Fewer Postoperative Complications After Neonatal Surgery: Analyses of the National Clinical Database Pediatric Surgical Registry in Japan
|
Hayashi, K.
|
|
|
26 |
12S |
p. S293
|
artikel
|
| 2272 |
PT26 How Aware Are Biotech and Pharmaceutical Companies of the Implementation of the New EU HTA?
|
Bean, S.
|
|
|
26 |
12S |
p. S392
|
artikel
|
| 2273 |
PT27 How Much Does TLV Value Rarity? A Review of Reimbursement Decisions on Orphan Drugs in Sweden from 2017 through 2022
|
Lanne, G.
|
|
|
26 |
12S |
p. S201
|
artikel
|
| 2274 |
PT34 Impact in Health Outcomes of PD-(L)1 Inhibitors to Treat Early Stages Cancers in Switzerland
|
Favre-Bulle, A.
|
|
|
26 |
12S |
p. S49
|
artikel
|
| 2275 |
PT16 Impact of Data Maturity on the Estimation of the within-Trial Hazard Function: An Example from Metastatic Castration Resistant Prostate Cancer
|
Williams, J.
|
|
|
26 |
12S |
p. S425-S426
|
artikel
|
| 2276 |
PT48 International Reference Pricing Analysis of Medicines in Turkiye By 2022
|
Citil, E.
|
|
|
26 |
12S |
p. S293
|
artikel
|
| 2277 |
PT23 Is It Possible to Estimate the Welfare Economic Loss to Society of Not Having Value-Based Differential Pricing for Multi-Indication Pharmaceuticals: An Empirical Analysis in Denmark, Norway, and Sweden
|
Ehlers, L.H.
|
|
|
26 |
12S |
p. S292
|
artikel
|
| 2278 |
PT28 Lost in PICO? a Simulation of the EU HTA Scoping Process
|
Buchholz, I.
|
|
|
26 |
12S |
p. S392
|
artikel
|
| 2279 |
PT35 Matching-Adjusted Indirect Comparison (MAIC) of Dabrafenib Plus Trametinib Versus Pembrolizumab Plus Chemotherapy in Patients with Treatment-Naive Metastatic BRAF V600 Mutation-Positive Non-Small Cell Lung Cancer (NSCLC)
|
Tai, T.A.
|
|
|
26 |
12S |
p. S49
|
artikel
|
| 2280 |
PT17 Modelling Treatment Duration in Psoriasis: Examining Extrapolation Approaches and Implications
|
Berkovitch, Q.
|
|
|
26 |
12S |
p. S426
|
artikel
|
| 2281 |
PT18 Novel Approaches to Unify Multi-State Transition Modelling Methods and Develop a Synthetic English Population to Support Health Economic Evaluation Studies
|
Kettle, J.
|
|
|
26 |
12S |
p. S426
|
artikel
|
| 2282 |
PT10 Opioid Tapering and Its Associations with Risk of Opioid Use Disorder and Mortality Among Older Adults
|
Yang, Y.
|
|
|
26 |
12S |
p. S48-S49
|
artikel
|
| 2283 |
PT11 Overall Survival of Patients with Lung Cancer Newly Diagnosed in the Period of the COVID-19 Pandemic Compared to Patients with an Incident Diagnosis Before the Pandemic: A Retrospective Analysis of German Claims Data
|
Krieger, J.
|
|
|
26 |
12S |
p. S254
|
artikel
|
| 2284 |
P36 Towards a Collaborative Value Assessment Framework for Provider-Facing Digital Health Technologies Used in Chronic Disease Management: Findings and Implications
|
Main, C.
|
|
|
26 |
12S |
p. S9
|
artikel
|
| 2285 |
PT4 Patient-Reported Outcomes (PROs) in German AMNOG-Assessments: Impact of Increasing the Response Threshold to 15 %
|
Fischer-Huchzermeyer, S.
|
|
|
26 |
12S |
p. S391
|
artikel
|
| 2286 |
PT12 Perceived Financial Burden and Quality of Life Among Patients with Cancer
|
Ruotsalainen, J.
|
|
|
26 |
12S |
p. S539-S540
|
artikel
|
| 2287 |
PT29 Predicting PICOs for EU Joint Clinical Assessment: Lessons from PICOs in Relative Effectiveness Assessments (REA) from EUnetHTA Joint Action 3 Project
|
Chamoux, C.
|
|
|
26 |
12S |
p. S392
|
artikel
|
| 2288 |
PT36 Real-World Analysis on Therapeutic Pattern and Economic Burden of Androgen-Receptor Signaling Inhibitors (ARSI) and Taxane-Based Chemotherapy Treated Metastatic Castration-Resistant Prostate Cancer Patients in Italy
|
Dovizio, M.
|
|
|
26 |
12S |
p. S540
|
artikel
|
| 2289 |
PT41 Real-World Evidence in Rare Diseases in France: Treatment Patterns, Healthcare Resource Use, and Related Costs in Von Willebrand Disease (FORvWARD Study)
|
Trossaërt, M.
|
|
|
26 |
12S |
p. S540
|
artikel
|
| 2290 |
PT24 Reimbursement Decisions in Ireland; Utilising Text Mining to Assess Factors Contributing to Decision Making
|
Gribbon, E.
|
|
|
26 |
12S |
p. S293
|
artikel
|
| 2291 |
P56 Trends in Prescription Drug Use Among Adults With Diabetes in the United States From 1999-2018
|
Li, S.
|
|
|
26 |
12S |
p. S14
|
artikel
|
| 2292 |
PT42 The Impact of Spinal Muscular Atrophy Type 2 on Caregivers in Argentina: Results of a Global Survey
|
Patel, A.
|
|
|
26 |
12S |
p. S540
|
artikel
|
| 2293 |
PT5 The Role of EUnetHTA 21 in Promoting Patient Engagement
|
Alshaikheid, M.
|
|
|
26 |
12S |
p. S391
|
artikel
|
| 2294 |
PT6 What Do Patients Value? Development of a Preference-Based Health Utility Score for Chronic Obstructive Pulmonary Disease (COPD)
|
Jones, B.
|
|
|
26 |
12S |
p. S391
|
artikel
|
| 2295 |
PT30 Will Health Technology Assessment (HTA) Bodies in Europe Accept Evidence from an External Control Arm to Supplement Evidence from Clinical Trials for Chronic Diseases?
|
Mangla, K.K.
|
|
|
26 |
12S |
p. S392
|
artikel
|
| 2296 |
P14 Understanding Patients' Preferences for Remote Monitoring in Parkinson's Disease: Insights from a Mixed-Methods Study
|
Godoy, C.
|
|
|
26 |
12S |
p. S3-S4
|
artikel
|
| 2297 |
P15 Unraveling Acceptance of Healthcare Innovations in Neurorehabilitation: A Systematic Approach Through Health Preference Research
|
Fischer, A.K.
|
|
|
26 |
12S |
p. S4
|
artikel
|
| 2298 |
P52 Validation of an Algorithm to Identify Lines of Therapy Among Adult Patients With Endometrial and Ovarian Cancer in a Real-World Dataset
|
Luhar, S.
|
|
|
26 |
12S |
p. S13
|
artikel
|
| 2299 |
P16 What Trade-Offs Are Women Willing to Make When Choosing Between Potential Treatments for Moderate-to-Severe Vasomotor Symptoms Due to Menopause?
|
Heidenreich, S.
|
|
|
26 |
12S |
p. S4
|
artikel
|
| 2300 |
Research Presentations Financial Disclosure Statements
|
|
|
|
26 |
12S |
p. S559-S575
|
artikel
|
| 2301 |
Reviewer Acknowledgement
|
|
|
|
26 |
12S |
p. A2-A5
|
artikel
|
| 2302 |
RWD94 Adaptation and Validation of a Natural Language Processing Algorithm to Use in Electronic Health Records to Identify Patients with Progressive Fibrosing-Interstitial Lung Disease in Spain
|
Balcells, E.
|
|
|
26 |
12S |
p. S522
|
artikel
|
| 2303 |
RWD175 A Data Quality Framework to Assess Healthcare Data in Saudi Arabia: An Automated Approach
|
Al-Jafar, R.
|
|
|
26 |
12S |
p. S538
|
artikel
|
| 2304 |
RWD119 A Decade of Alzheimer's Disease Management in Germany: The Increasing Impact of Specialists
|
Wartmann, H.
|
|
|
26 |
12S |
p. S526
|
artikel
|
| 2305 |
RWD135 A Demographic Description of Women With Uncomplicated Urinary Tract Infection in England: A Primary Care Electronic Health Records and Notes Review
|
Brewer, H.
|
|
|
26 |
12S |
p. S530
|
artikel
|
| 2306 |
RWD125 A Health-Related Cost and Mortality Comparison Between Early and Late-Stage Lung Cancer: A Retrospective Cohort Study from a Brazilian Health Management Organization (HMO)
|
Reis Neto, J.P.
|
|
|
26 |
12S |
p. S528
|
artikel
|
| 2307 |
RWD52 A Machine Learning Model to Facilitate Patient-Level Risk Screening in Myelodysplastic Syndromes (MDS) Patients in Routine Clinical Practice
|
Vaidya, V.
|
|
|
26 |
12S |
p. S514
|
artikel
|
| 2308 |
RWD120 Analysis of the Impact of National Medical Insurance Negotiation Policy on the Accessibility of Anti-Cancer Drugs in a City in China
|
Li, B.
|
|
|
26 |
12S |
p. S526-S527
|
artikel
|
| 2309 |
RWD180 Analyzing Medical Patterns and Catastrophic Health Expenses in Occupational Injuries Victims in South Korea
|
Cha, Y.
|
|
|
26 |
12S |
p. S539
|
artikel
|
| 2310 |
RWD131 A Nationwide Feasibility Study and Study Concept to Assess the Burden of Duchenne Muscular Dystrophy (DMD) in Finland
|
Kyttälä, M.
|
|
|
26 |
12S |
p. S529
|
artikel
|
| 2311 |
RWD64 A Nationwide Population-Based Study of Herbal Medicine for the Treatment of Functional Dyspepsia
|
Lee, B.
|
|
|
26 |
12S |
p. S516
|
artikel
|
| 2312 |
RWD75 An Innovative Data Collection System for Improving Outcomes in Patients Treated with Diabetes Technology
|
Buompensiere, M.I.
|
|
|
26 |
12S |
p. S518
|
artikel
|
| 2313 |
RWD81 Annual Nationwide Epidemiological and Health Insurance Burden of Hip Osteoarthritis in Hungary: A Burden of Disease Study Based on Real World Data
|
Kajos, L.
|
|
|
26 |
12S |
p. S519
|
artikel
|
| 2314 |
RWD60 APNEE Study: A Challenge to Identify Patients Treated with Dupilumab for Chronic Rhinosinusitis with Nasal Polyps (CRSWNP) in Real-Life Settings in France
|
Papon, J.F.
|
|
|
26 |
12S |
p. S515-S516
|
artikel
|
| 2315 |
RWD51 Application of Real-World Data Sources for Equity-Informed Evaluations of Multiple Myeloma
|
Ricci, S.
|
|
|
26 |
12S |
p. S513-S514
|
artikel
|
| 2316 |
RWD30 Applying Transportability Methods to Real-World Data: A Scoping Review
|
Wang, H.
|
|
|
26 |
12S |
p. S510
|
artikel
|
| 2317 |
RWD150 A Prescription Pattern of HIV First-Line Tenofovir Alafenamide-Based Single-Tablet Regimens: A Multi-Institutional Study in Taiwan
|
Lin, H.Y.
|
|
|
26 |
12S |
p. S533
|
artikel
|
| 2318 |
RWD53 A Real-World Analysis of Treatment Patterns for First-Line Immunotherapies Among Danish Patients with Non-Small Cell Lung Cancer (NSCLC) and PD-L1 Expression ≥50%
|
Clugston, D.M.
|
|
|
26 |
12S |
p. S514
|
artikel
|
| 2319 |
RWD115 Assessing and Comparing Inpatient Hospitalization for Mental Disorders in the United States and European OECD Countries
|
Lee, R.
|
|
|
26 |
12S |
p. S526
|
artikel
|
| 2320 |
RWD134 Assessing the Association between Pain Burden and Limitations Among Older United States Adults with Pain who Used Opioids
|
Axon, D.
|
|
|
26 |
12S |
p. S530
|
artikel
|
| 2321 |
RWD76 Assessing the External Validity of Thin Database in Spain: A Reliable Source of Real-World Data for Observational Retrospective Research
|
Valente, A.
|
|
|
26 |
12S |
p. S518
|
artikel
|
| 2322 |
RWD40 Assessing the Representativeness of Body Mass Index Categories Across Multiple Types of Secondary Data Sources
|
Boulanger, L.
|
|
|
26 |
12S |
p. S511-S512
|
artikel
|
| 2323 |
RWD126 Assessment of Cutaneous Malignant Melanoma Knowledge, Tanning Attitude, and Sun-Protective Behavior in Greece: A Significant Gap in the National Preventive Health Strategy
|
Kapaki, V.
|
|
|
26 |
12S |
p. S528
|
artikel
|
| 2324 |
RWD166 Assessment of Haemophilia Management in Algeria: Challenges and Perspectives
|
Cherif, N.
|
|
|
26 |
12S |
p. S536-S537
|
artikel
|
| 2325 |
RWD157 Assessment of Real-World Treatment Patterns and Healthcare Resource Utilization (HCRU) in Patients with Lenalidomide-Refractory Relapsed/Refractory Multiple Myeloma (RRMM) from the US Optum Database
|
Costa, L.
|
|
|
26 |
12S |
p. S534-S535
|
artikel
|
| 2326 |
RWD85 A Systematic Literature Review on the Use of Real-World Evidence in NICE Technology Appraisals Indicated for Multiple Myeloma
|
Dempsey, J.
|
|
|
26 |
12S |
p. S520
|
artikel
|
| 2327 |
RWD143 Beyond Accuracy: Automated De-Identification of Large Real-World Clinical Text Datasets
|
Kocaman, V.
|
|
|
26 |
12S |
p. S532
|
artikel
|
| 2328 |
RWD5 Body Fatness Associations with Cancer: Retrospective Cohort Study from a Brazilian Health Management Organization (RWE)
|
Busch, J.
|
|
|
26 |
12S |
p. S504
|
artikel
|
| 2329 |
RWD84 Building Federated Data Networks With Common Data Models to Generate Insights Through Real-World Evidence Observational Studies in Oncology
|
Oeste, C.
|
|
|
26 |
12S |
p. S519-S520
|
artikel
|
| 2330 |
RWD96 Burden of Chronic Obstructive Pulmonary Disease (COPD) Patients Uncontrolled Despite Triple-Therapy in France
|
Antoniali, L.
|
|
|
26 |
12S |
p. S522
|
artikel
|
| 2331 |
RWD1 Capacity-Enhancing Innovation (CEI) and the Treatment of Severe Symptomatic Aortic Stenosis (sSAS) in England
|
Sarmah, A.
|
|
|
26 |
12S |
p. S504
|
artikel
|
| 2332 |
RWD2 Catheter Ablation to Treat Cardiac Arrhythmia in Germany – Trends Based on German Hospital Data
|
Theil, J.
|
|
|
26 |
12S |
p. S504
|
artikel
|
| 2333 |
RWD124 Characteristics of Patients with Advanced Endometrial Cancer Who Received Pembrolizumab As Part of an Early Access Program (EAP) in Accordance with KN-775 Labelling
|
Cagnan, L.
|
|
|
26 |
12S |
p. S527-S528
|
artikel
|
| 2334 |
RWD86 Characteristics of Patients with Locally Recurrent Unresectable or Metastatic Triple-Negative Breast Cancer Who Received Pembrolizumab as Part of an Early Access Program in Accordance with KN-355 Labelling
|
Cagnan, L.
|
|
|
26 |
12S |
p. S520
|
artikel
|
| 2335 |
RWD34 Characterization and Trends of Non-Hypothesis Evaluating Treatment Effectiveness (Non-HETE) Studies
|
Sheth, S.
|
|
|
26 |
12S |
p. S510
|
artikel
|
| 2336 |
RWD99 Characterization of Comorbidities and Economic Burden in US Medicare Beneficiaries with Systemic Lupus Erythematosus with and without Lupus Nephritis
|
Nair, A.
|
|
|
26 |
12S |
p. S523
|
artikel
|
| 2337 |
RWD66 Characterization of the Variation of Opioid Prescription in 15 Dutch Hospitals: A Real World Data Analysis
|
Gal, P.
|
|
|
26 |
12S |
p. S517
|
artikel
|
| 2338 |
RWD18 Characterization of Time-to-Treatment-Discontinuation (TTTD) as a Proxy for Progression-Free Survival (PFS) in Real-World Evidence (RWE) Based Analyses of Relapsed-Refractory Multiple Myeloma (RRMM)
|
O'Reilly, J.
|
|
|
26 |
12S |
p. S507
|
artikel
|
| 2339 |
RWD173 Chronification in the Use of Benzodiacepines: Incidence Stratified by Sex and Age Groups
|
Aznar-Lou, I.
|
|
|
26 |
12S |
p. S538
|
artikel
|
| 2340 |
RWD63 Clinical Outcomes in Non-Inhibitor Severe Haemophilia A Patients Receiving Prophylaxis Across Currently Available Haemophilia A Treatments: Insights Form the ‘Cost of Haemophilia: A Socioeconomic Survey III’ (CHESS III) Study
|
Blenkiron, T.
|
|
|
26 |
12S |
p. S516
|
artikel
|
| 2341 |
RWD144 Coded Diagnoses Versus Proxy-Based Diagnoses in Primary Care: Registration By General Practitioners in the PHARMO GP Data
|
Overbeek, J.
|
|
|
26 |
12S |
p. S532
|
artikel
|
| 2342 |
RWD39 Comparative Effectiveness and Health Resource Utilization of Xuesaitong Soft Capsule in Patients with Stroke of Secondary Prevention in China: A Retrospective Cohort Study
|
Wang, C.
|
|
|
26 |
12S |
p. S511
|
artikel
|
| 2343 |
RWD159 Comparison of Livingstone's Estimates of Prevalence of Six Different Rare Blood Cancers with Darwin EU
|
Heywood, B.R.
|
|
|
26 |
12S |
p. S535
|
artikel
|
| 2344 |
RWD100 Comparison of Real-World Safety and Effectiveness of Mepolizumab and Benralizumab in the Management of Severe Asthma: A Systematic Review
|
Bhavanasai, S.
|
|
|
26 |
12S |
p. S523
|
artikel
|
| 2345 |
RWD23 Comparison of the Use of Real-World Evidence (RWE) by Health Technology Assessment (HTA) Agencies in Reviews of Drugs for Rare Diseases (DRDS)
|
Kirby, J.
|
|
|
26 |
12S |
p. S508
|
artikel
|
| 2346 |
RWD117 Comparison the Annual, Nationwide Health Insurance Treatment Cost of Hip Osteoarthritis Based on Routinely Collected Financing Data in 2010 and 2018 in Hungary
|
Kajos, L.
|
|
|
26 |
12S |
p. S526
|
artikel
|
| 2347 |
RWD129 Cost Effectiveness of Onasemnogene Abeparvovec in Infants with Presymptomatic Spinal Muscular Atrophy in Italy
|
Valentini, I.
|
|
|
26 |
12S |
p. S528-S529
|
artikel
|
| 2348 |
RWD6 Costs of Dose Escalation Among Patients with Inflammatory Bowel Disease Treated with Vedolizumab and Ustekinumab in Portugal
|
Lopes da Cruz, J.P.
|
|
|
26 |
12S |
p. S504-S505
|
artikel
|
| 2349 |
RWD133 Cross Sectional Claims Data Analysis on Myopia Epidemiology and Treatment Options in Germany
|
Pignot, M.
|
|
|
26 |
12S |
p. S529
|
artikel
|
| 2350 |
RWD24 Decision Making and the Questions Raised When Real World Evidence From a Federated Data Network Conflicts With RCT Data: A Use Case on COVID-19 Treatments
|
Read, C.
|
|
|
26 |
12S |
p. S508
|
artikel
|
| 2351 |
RWD45 Describing Medication Switching Patterns Among Adults With Rheumatoid Arthritis From 2016-2022 Using Real-World Data
|
Djibo, D.A.
|
|
|
26 |
12S |
p. S512
|
artikel
|
| 2352 |
RWD152 Describing the Management of Spondyloarthropathies in French Primary Care: An EHR Study Exploring Regional Differences
|
Ducros, M.
|
|
|
26 |
12S |
p. S533
|
artikel
|
| 2353 |
RWD145 Devastating Loss of Life Expectancy and Quality-Adjusted Life Years after Stroke in Brazil: A Focus on Hemorrhagic Subtypes
|
Magalhães, P.
|
|
|
26 |
12S |
p. S532
|
artikel
|
| 2354 |
RWD29 Development of a Comprehensive List of Immunosuppressive Therapies to Enable a Multi-Data Source Global Real-World Effectiveness (RWE) Program of Immunocompromised Patients
|
Kamauu, A.W.
|
|
|
26 |
12S |
p. S509-S510
|
artikel
|
| 2355 |
RWD26 Dupixam: An Algorithm to Identify Patients with Atopic Dermatitis Among Dupilumab-Treated Population Using the SNDS (SYSTEME NATIONAL DES DONNEES DE SANTE) in France
|
Allali, N.
|
|
|
26 |
12S |
p. S509
|
artikel
|
| 2356 |
RWD62 Dupixam: An SNDS (SYSTÈME NATIONAL DES DONNÉES DE SANTÉ) Study to Characterize Patients Treated with Dupilumab for Moderate-to-Severe Atopic Dermatitis in France
|
Allali, N.
|
|
|
26 |
12S |
p. S516
|
artikel
|
| 2357 |
RWD59 Economic and Healthcare Resource Utilization by Transthyretin Amyloid Cardiomyopathy Patients in Spain: Observations From the PRACTICA Study
|
Peral, C.
|
|
|
26 |
12S |
p. S515
|
artikel
|
| 2358 |
RWD153 Economic and Humanistic Burden Among Patients With Non-Radiographic Axial Spondyloarthritis in China
|
Xu, X.
|
|
|
26 |
12S |
p. S533-S534
|
artikel
|
| 2359 |
RWD89 Economic Burden of Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Harboring KRASG12C Mutation in Spain
|
Fernández-Barceló, C.
|
|
|
26 |
12S |
p. S521
|
artikel
|
| 2360 |
RWD22 Economic Burden of Moderate and Severe Hemophilia A and B in Spain, Real-World Evidence Insights from the Cost of Hemophilia in Europe: A Socio-Economic Survey II (CHESS II) Study
|
Peral, C.
|
|
|
26 |
12S |
p. S508
|
artikel
|
| 2361 |
RWD176 Economic Results Generated By Optimizing a Parenteral Medication Application Process
|
Londoño, M.
|
|
|
26 |
12S |
p. S538
|
artikel
|
| 2362 |
RWD14 Endometrial Cancer First Line Treatment in Argentina: ECHOS-A Real-World Study
|
Abreu, G.
|
|
|
26 |
12S |
p. S506
|
artikel
|
| 2363 |
RWD95 Eosinophilic Granulomatosis with Polyangiitis: Estimation of the Clinical and Economic Burden in France: A Real-World Retrospective Study Based on the National Health Data System (SNDS)
|
Tauty, S.
|
|
|
26 |
12S |
p. S522
|
artikel
|
| 2364 |
RWD83 Epidemiological Characterization of the Current Patient Population of Multiple Sclerosis Patients Enrolled in a Patient Registry for Interferon-Beta 1a SC in Portugal
|
Ribeiro, M.
|
|
|
26 |
12S |
p. S519
|
artikel
|
| 2365 |
RWD168 Epidemiology of Respiratory Syncytial Virus in Uppsala and Stockholm: A Population-Based Study
|
Varghese, N.E.
|
|
|
26 |
12S |
p. S537
|
artikel
|
| 2366 |
RWD158 Estimates on Waste of Breast Cancer Related Chemotherapy Drugs in the NHS (ENGLAND)
|
Edmonds, T.
|
|
|
26 |
12S |
p. S535
|
artikel
|
| 2367 |
RWD50 Evaluation and Improvement of a NHDS Algorithm to Detect Patients With Metastatic Breast Cancer and HER2+ Status Using a RWE NLP-Powered Solution
|
Rejasse, G.
|
|
|
26 |
12S |
p. S513
|
artikel
|
| 2368 |
RWD92 Evaluation of Second and Third Generation Tyrosine Kinase Inhibitor As First-Line Therapy for Non–Small-Cell Lung Cancer Patients: A Multi-Institutional Study in Taiwan
|
Cheng, Y.W.
|
|
|
26 |
12S |
p. S521
|
artikel
|
| 2369 |
RWD151 Evaluation of the Effect of Methodological Assumptions on Estimates of Adherence to Antipsychotics: A Real-World Data Study
|
Fuente-Moreno, M.
|
|
|
26 |
12S |
p. S533
|
artikel
|
| 2370 |
RWD162 Evolution of Breast Cancer Treatment Cost in the Last 36 Months: An Analysis From a Health Payer Perspective in Brazil
|
Reis Neto, J.P.
|
|
|
26 |
12S |
p. S535-S536
|
artikel
|
| 2371 |
RWD139 Exploring Respiratory Syncytial Virus and Influenza Trends Pre- and Post-COVID-19 in the US and EU-5 Countries
|
Proshenska, D.
|
|
|
26 |
12S |
p. S531
|
artikel
|
| 2372 |
RWD73 Exposing the True Economic Impact of Stroke: A Comparative Analysis of Time-Driven Activity-Based Costing and Reimbursement Methods in Brazil
|
Diegoli, H.
|
|
|
26 |
12S |
p. S518
|
artikel
|
| 2373 |
RWD112 Factors Associated with High Costs of Patients with Non-Alcoholic Fatty Liver Disease: An Observational Study Using the French Constances Cohort
|
Arnaud, N.O.
|
|
|
26 |
12S |
p. S525
|
artikel
|
| 2374 |
RWD122 First and Second Line Treatment Choices for Endometrial Cancer: ECHOS-A Real-World Study
|
Abreu, G.
|
|
|
26 |
12S |
p. S527
|
artikel
|
| 2375 |
RWD142 Global Use of Nordic Real-World Evidence: A Systematic Review of Published Literature and HTA Submissions
|
Kaushik, P.
|
|
|
26 |
12S |
p. S531
|
artikel
|
| 2376 |
RWD7 Graphical Representation of Real-World Data for Analysing Infection Outbreaks Within a Tertiary Hospital Setting: A Data-Driven Approach
|
Gualda Gea, J.
|
|
|
26 |
12S |
p. S505
|
artikel
|
| 2377 |
RWD98 Health Care Resource Use and Costs of Hemophilia A in France
|
Cahoreau, V.
|
|
|
26 |
12S |
p. S522-S523
|
artikel
|
| 2378 |
RWD28 Healthcare Resource Utilization and Cost of Renal Replacement Therapy in Brazil: A Five-Year Patient-Level Analysis
|
Lopes, N.
|
|
|
26 |
12S |
p. S509
|
artikel
|
| 2379 |
RWD171 Healthcare Resource Utilization and Cost of Renal Replacement Therapy in Brazil: A Five-Year Procedure-Level Analysis
|
Lopes, N.
|
|
|
26 |
12S |
p. S537
|
artikel
|
| 2380 |
RWD25 Healthcare Resource Utilization and Costs in Patients Experiencing Severe Cardiac Events Following a COPD Exacerbation: Results from EXACOS-CV Studies in Spain, Germany, the Netherlands and Canada
|
Parsekar, K.
|
|
|
26 |
12S |
p. S508-S509
|
artikel
|
| 2381 |
RWD130 Healthcare Resource Utilization for Pediatric and Adolescent Duchenne Muscular Dystrophy Patients: Analysis of Real-World Data
|
Strober, J.
|
|
|
26 |
12S |
p. S529
|
artikel
|
| 2382 |
RWD20 Health Care Resource Utilization Patterns in Finnish Multiple Myeloma Patients: A Population-Based Cohort Study
|
Metsä, R.
|
|
|
26 |
12S |
p. S507
|
artikel
|
| 2383 |
RWD35 Health Status Changes of Refugees from North Korea After Defection: Using National-Wide Big Data in South Korea
|
Lee, J.
|
|
|
26 |
12S |
p. S510-S511
|
artikel
|
| 2384 |
RWD32 Hearing the Patient Voice in Japan – Utilisation of Patient-Reported Outcomes and Wearable Device Data for Patient-Centric Real-World Research
|
Hamaguchi, A.
|
|
|
26 |
12S |
p. S510
|
artikel
|
| 2385 |
RWD91 Hospital Efficiency Impact of Spectral CT Versus Conventional CT in Diagnosis of Patients Suspected of Occult Cancer in the UK
|
Verma, S.
|
|
|
26 |
12S |
p. S521
|
artikel
|
| 2386 |
RWD78 Hospitalization Costs for Patients with Acute Appendicitis: An Update Using Real-World Data from a Large Province in China
|
Peng, N.
|
|
|
26 |
12S |
p. S518-S519
|
artikel
|
| 2387 |
RWD141 How Global Datasets Can Shed Light on Health Inequalities: An Environmental Scan of Publicly Available Sources
|
Vinals, L.
|
|
|
26 |
12S |
p. S531
|
artikel
|
| 2388 |
RWD68 How Pharmaceutical, Biotechnology and Medical Technology Companies Use Clinical Practice Research Datalink (CPRD) Data: Rapid Structured Review Using Machine Learning
|
Kopecky, L.
|
|
|
26 |
12S |
p. S517
|
artikel
|
| 2389 |
RWD90 How to Reduce the Burden of Travel for the Patients? a Proof of Concept (POC) for Oncological Oral Drugs Distribution Points Analysis
|
Cavallucci, M.
|
|
|
26 |
12S |
p. S521
|
artikel
|
| 2390 |
RWD48 Identification and Assessment of Real-World Oncology Data in China: A Data Landscaping Study
|
Ban, L.
|
|
|
26 |
12S |
p. S513
|
artikel
|
| 2391 |
RWD105 Identifying and Appraising Fit-for-Purpose Data Sources for Real World Evidence Studies: A Structured Approach to Conducting Data Source Feasibility Assessments
|
Matthews, H.
|
|
|
26 |
12S |
p. S524
|
artikel
|
| 2392 |
RWD161 Identifying and Characterizing Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Population in Finland
|
Ruotsalainen, J.
|
|
|
26 |
12S |
p. S535
|
artikel
|
| 2393 |
RWD16 Identifying Oncology Effectiveness Endpoints Using Administrative Secondary Databases: An Example Utilising Hospital Episode Statistics in England
|
Rolfe, C.
|
|
|
26 |
12S |
p. S506
|
artikel
|
| 2394 |
RWD9 Identifying Predictors of Response Following Discontinuation of JAKi Therapy in Patients with Rheumatoid Arthritis
|
De Cock, D.
|
|
|
26 |
12S |
p. S505
|
artikel
|
| 2395 |
RWD36 Immunoglobulin Use in France 2015 to 2022–Real-World Data From the French Claims Database
|
Darlington, M.
|
|
|
26 |
12S |
p. S511
|
artikel
|
| 2396 |
RWD58 Impact of Bleeds on the Quality of Life of Patients with Haemophilia: Results from a Multinational Real-World Survey
|
Thakkar, S.
|
|
|
26 |
12S |
p. S515
|
artikel
|
| 2397 |
RWD132 Impact of Exacerbations on Disease Burden of COPD: A Retrospective Observational Database Cohort Study in Tianjin, China
|
Gan, L.
|
|
|
26 |
12S |
p. S529
|
artikel
|
| 2398 |
RWD79 Impact of Google Searches on Suicide Rates in Colombia
|
Pérez Mendoza, S.
|
|
|
26 |
12S |
p. S519
|
artikel
|
| 2399 |
RWD21 Impact of Haemophilia Severity on Healthcare Resource Usage: Results from a Multinational Real-World Survey
|
Thakkar, S.
|
|
|
26 |
12S |
p. S507
|
artikel
|
| 2400 |
RWD38 Implement a Direct-to-Patient Application to Recruit Diverse Patients and Collect Real-World Data
|
Zhang, Y.
|
|
|
26 |
12S |
p. S511
|
artikel
|
| 2401 |
RWD181 Improving Clinical Practice and Patient-Centric Care through Digital Outcome Measurement Tools
|
Vutova, Y.
|
|
|
26 |
12S |
p. S539
|
artikel
|
| 2402 |
RWD165 Improving Evidence Generation From Rare Disease Registries: Performing Variable Gap Analyses
|
Cosmatos, I.
|
|
|
26 |
12S |
p. S536
|
artikel
|
| 2403 |
RWD61 Inclusion of Productivity Losses and Gains in Cost-Effectiveness Analyses in Psoriasis: Preliminary Report of a Brazilian Association of Psoriasis (LATAM/LMIC)
|
Tanaka, E.
|
|
|
26 |
12S |
p. S516
|
artikel
|
| 2404 |
RWD101 Intravitreal Therapies and Their Patterns of Use in Lombardy Region
|
Foglia, E.
|
|
|
26 |
12S |
p. S523
|
artikel
|
| 2405 |
RWD170 Investigating the Association between Pain Burden and Multimorbidity Among United States Adults with Pain
|
Axon, D.
|
|
|
26 |
12S |
p. S537
|
artikel
|
| 2406 |
RWD88 Investigating the Transferability, at the National Level, of Results from Hemsys, a French Multidisciplinary Concertation Meetings Database in Onco-Hematology, to Generate Real-World Evidence
|
Houot, R.
|
|
|
26 |
12S |
p. S520
|
artikel
|
| 2407 |
RWD80 Labor Impact in Patients with Rheumatoid Arthritis (RA) Treated with Advanced Therapies
|
Silva, L.
|
|
|
26 |
12S |
p. S519
|
artikel
|
| 2408 |
RWD110 Lifetime Costs of Stroke in Brazil with a Focus on Hemorrhagic Subtypes
|
Diegoli, H.
|
|
|
26 |
12S |
p. S525
|
artikel
|
| 2409 |
RWD17 Methodology for the Development of a Data Collection Tool
|
Gonzalez Durio, J.
|
|
|
26 |
12S |
p. S506-S507
|
artikel
|
| 2410 |
RWD121 Moment Registry (MET NON SMALL CELL CANCER REGISTRY) for Advanced Non-Small Cell Lung Cancer (ANSCLC) Harboring MET Exon 14 (METEX14) Skipping
|
Thomas, M.
|
|
|
26 |
12S |
p. S527
|
artikel
|
| 2411 |
RWD47 Non-Motor Symptoms Burden and Quality of Life in Patients with Parkinson’s Disease (PD)
|
Nasuti, P.
|
|
|
26 |
12S |
p. S513
|
artikel
|
| 2412 |
RWD103 NVX-CoV2373 Patient Characteristics in Germany: Real-World Retrospective Database Study Shows Most Vaccine Recipients Were Among the High Risk Category
|
Adam, A.
|
|
|
26 |
12S |
p. S524
|
artikel
|
| 2413 |
RWD27 Opportunities and Challenges in Linkage of Early Access Databases With the French National Claims Database: A RWE Effectiveness Study of AZD7442 for Pre-Exposure Prophylaxis Against COVID-19 in Immunocompromised Patients
|
Luong, L.
|
|
|
26 |
12S |
p. S509
|
artikel
|
| 2414 |
RWD65 Patterns of Antibiotic Prescribing in a Tertiary Hospital Using Real-World Data
|
Ankrah, D.
|
|
|
26 |
12S |
p. S517
|
artikel
|
| 2415 |
RWD37 Pre-/Post Prevalence of Cardiovascular Diseases in Hospitalized COVID Patients: A German Claims Data Analysis
|
Appiah, K.
|
|
|
26 |
12S |
p. S511
|
artikel
|
| 2416 |
RWD140 Quality of Electronic Health Records: Encountering Misclassification
|
Jaffe, D.
|
|
|
26 |
12S |
p. S531
|
artikel
|
| 2417 |
RWD93 Quantifying Trends in Price Setting for Traditional and Innovative Advanced Rare Disease Therapies
|
Brown, C.
|
|
|
26 |
12S |
p. S521-S522
|
artikel
|
| 2418 |
RWD149 Real-Life Dose Escalation of Patients with Ulcerative Colitis and Crohn’s Disease Undergoing Biologic Treatment in Portugal
|
Lopes da Cruz, J.P.
|
|
|
26 |
12S |
p. S533
|
artikel
|
| 2419 |
RWD77 Real-World Data Analysis Showing a Significant Improvement in Glycemic Control of People with T2D in Poland When Using a Blood Glucose Meter Connected to a Mobile Health App
|
Arnaut, T.
|
|
|
26 |
12S |
p. S518
|
artikel
|
| 2420 |
RWD108 Real-World Data and Real-World Evidence Terminology Harmonization: Evidence Gaps and Future Steps
|
Chhaya, V.
|
|
|
26 |
12S |
p. S524-S525
|
artikel
|
| 2421 |
RWD56 Real World Data for Planning a New Organised Cancer Screening Programme in the Czech Republic: Example of Prostate Cancer Screening
|
Hejcmanová, K.
|
|
|
26 |
12S |
p. S514-S515
|
artikel
|
| 2422 |
RWD147 Real-World Data of Therapeutic Inertia in Diabetes in a Health Care Intitution
|
Realpe, O.
|
|
|
26 |
12S |
p. S532
|
artikel
|
| 2423 |
RWD54 Real-World Evidence for Patient Outcomes and Mutational Burden in Non-Small Cell Lung (NSCLC) Cancer Patients in England Using EGFR Biomarker Test Data from Routine Clinical Care
|
Hagenaars, S.
|
|
|
26 |
12S |
p. S514
|
artikel
|
| 2424 |
RWD49 Real-World Evidence From a Federated Data Network to Reduce Uncertainty in the Long-Term Extrapolations of Oncology Treatments
|
Dietz, J.
|
|
|
26 |
12S |
p. S513
|
artikel
|
| 2425 |
RWD178 Real-World Evidence in Post-Authorization Studies: Review of European Databases in the ENCePP EU Pas Register® Between 2010 – 2023
|
Chioureas, D.
|
|
|
26 |
12S |
p. S538-S539
|
artikel
|
| 2426 |
RWD137 Real-World Osteoporosis Drug Utilization in Patients with Recurrent Osteoporotic Fracture: A Nationwide Cohort Study in South Korea
|
Han, H.
|
|
|
26 |
12S |
p. S530
|
artikel
|
| 2427 |
RWD11 Real-World Persistence on Cladribine Tablets of Patients with RMS over 4 Years Based on Claims Data
|
Giesl, N.
|
|
|
26 |
12S |
p. S505-S506
|
artikel
|
| 2428 |
RWD156 Real-World Progression Patterns in First and Second Lines of Systemic Therapy for Endometrial Cancer
|
Abreu, G.
|
|
|
26 |
12S |
p. S534
|
artikel
|
| 2429 |
RWD10 Real-World Safety and Effectiveness of Sodium Oxybate in the Management of Narcolepsy: A Systematic Literature Review
|
Kandregula, N.
|
|
|
26 |
12S |
p. S505
|
artikel
|
| 2430 |
RWD169 Resource Utilization of Different Remission and Relapse Profiles in Chronic Urticaria—Results From Predict-CSU Real-World Study in the United States
|
Balp, M.M.
|
|
|
26 |
12S |
p. S537
|
artikel
|
| 2431 |
RWD87 Retrospective Observational Study of Patients with Metastatic Merkel Cell Carcinoma (mMCC) Using the Caraderm Database Linked to the French National Health Data System (SNDS)
|
Blom, A.
|
|
|
26 |
12S |
p. S520
|
artikel
|
| 2432 |
RWD55 Retrospective Observational Study of Real-World Treatment Patterns and Financial Burden in Patients With Premenopausal Metastatic HR+/HER2- Breast Cancer
|
Koh, H.
|
|
|
26 |
12S |
p. S514
|
artikel
|
| 2433 |
RWD138 Rising Adoption of Healthcare Wearables in Clinical Study Design
|
Wellam, H.
|
|
|
26 |
12S |
p. S530-S531
|
artikel
|
| 2434 |
RWD19 Risk of Death Before and After Metastasis in High-Risk Localized and Locally Advanced Prostate Cancer Patients Undergoing Radical Prostatectomy or Radiotherapy as Primary Treatment in the United States: A Retrospective Study
|
Freedland, S.
|
|
|
26 |
12S |
p. S507
|
artikel
|
| 2435 |
RWD104 Shifting Tides: Unveiling the Burden of Demographic Change in Germany Through Administrative Hospital Data
|
Stremel, T.
|
|
|
26 |
12S |
p. S524
|
artikel
|
| 2436 |
RWD4 Socioeconomic Burden of Obesity – Increased Rate and Duration of Sick Leave in Patients Living with Obesity: A Cross-Sectional Claims Data Analysis in Germany
|
Timpel, P.
|
|
|
26 |
12S |
p. S504
|
artikel
|
| 2437 |
RWD72 Status of the Art on Global Clinical Trials of Patient-Managed Digital Medical Devices (pDMD): 2023 Original Data Analysis From Multiple Sources
|
Pagella, V.
|
|
|
26 |
12S |
p. S517-S518
|
artikel
|
| 2438 |
RWD42 Stoma-Related Outcomes and Costs Associated with Initial Stoma Product Selection – Findings from a Swedish Register and Chart Review Study
|
Forsmark, A.
|
|
|
26 |
12S |
p. S512
|
artikel
|
| 2439 |
RWD172 Strategies for the Rational Use of Biologic Therapies in an Integrated Clinic for Immune-Mediated Skin Diseases
|
Londoño, A.M.
|
|
|
26 |
12S |
p. S537-S538
|
artikel
|
| 2440 |
RWD8 Study of the Mental Health of Pharmacists During Wartime in Ukraine
|
Maksymovych, N.
|
|
|
26 |
12S |
p. S505
|
artikel
|
| 2441 |
RWD113 Switching to TNFi Versus Non-TNFi Biologics in Ulcerative Colitis Patients: Real-World Outcomes from a German Claims Data Analysis
|
Zhuleku, E.
|
|
|
26 |
12S |
p. S525-S526
|
artikel
|
| 2442 |
RWD97 Systematic Identification, Access, and Utility Mapping of Asia Pacific Real-World Data Sources for Rare and Non-Rare Retinal Diseases
|
Hogg, L.
|
|
|
26 |
12S |
p. S522
|
artikel
|
| 2443 |
RWD127 Systemic Treatment of Non-Melanoma Skin Cancers in France: Real-World Analysis Using French Data from the National Hospitalization Database
|
Perrier, S.
|
|
|
26 |
12S |
p. S528
|
artikel
|
| 2444 |
RWD128 The Burden of Illness in Duchenne Muscular Dystrophy: Evidence Gaps and Research Needs
|
Simpson, A.
|
|
|
26 |
12S |
p. S528
|
artikel
|
| 2445 |
RWD163 The Economic Burden of Cutaneous Malignant Melanoma in Greece: Analysis of Real-Word Health Insurance Data
|
Kapaki, V.
|
|
|
26 |
12S |
p. S536
|
artikel
|
| 2446 |
RWD116 The Economic Burden of Moderate to Severe Rheumatoid Arthritis (RA) in Spain: Interim 6-Month Results
|
Balsa, A.
|
|
|
26 |
12S |
p. S526
|
artikel
|
| 2447 |
RWD67 The Health Resource Utilization and Medical Costs of Cataract Surgery in Pediatric Patients: A National Population-Based Study in a Korea
|
Jang, S.
|
|
|
26 |
12S |
p. S517
|
artikel
|
| 2448 |
RWD31 The Impact of Advanced Training on Operational Efficiency in Robotic-Assisted Rectal Resection
|
D'Attilio, D.
|
|
|
26 |
12S |
p. S510
|
artikel
|
| 2449 |
RWD123 The Impact of COVID-19 on Treatment of Patients With Ovarian Cancer in England
|
Wallis, J.
|
|
|
26 |
12S |
p. S527
|
artikel
|
| 2450 |
RWD164 The Impact of Spinal Muscular Atrophy (SMA) Type 1 on Caregivers in Taiwan: Results of a Global Survey
|
Patel, A.
|
|
|
26 |
12S |
p. S536
|
artikel
|
| 2451 |
RWD106 The Maze of RWE Frameworks: An Environmental Scanning and Comparison Across Regulatory and HTA Bodies
|
Sarri, G.
|
|
|
26 |
12S |
p. S524
|
artikel
|
| 2452 |
RWD102 The Real-World Effectiveness of Tixagevimab and Cilgavimab in Immunocompromised Patients: A Single Center Study in Taiwan
|
Yu, H.C.
|
|
|
26 |
12S |
p. S523-S524
|
artikel
|
| 2453 |
RWD160 Time to Treatment Initiation and Patient Characteristics in Newly Diagnosed Multiple Myeloma Patients With and Without Transplant: Real-World Evidence Using Big Data From England
|
Pawlyn, C.
|
|
|
26 |
12S |
p. S535
|
artikel
|
| 2454 |
RWD13 Treatment Pathways and Outcomes of Advanced Ovarian Cancer Patients Who Are Underrepresented in Trials
|
Picariello, F.
|
|
|
26 |
12S |
p. S506
|
artikel
|
| 2455 |
RWD57 Treatment Patterns and Cost of Care Among Patients With Metachromatic Leukodystrophy (MLD) in the US
|
Mohajer, A.
|
|
|
26 |
12S |
p. S515
|
artikel
|
| 2456 |
RWD136 Use and Potential of Real-World Data (RWD) and Real-World Evidence (RWE) to Inform Pre-Market Regulatory Decisions: A Scoping Review
|
Lockhart, C.
|
|
|
26 |
12S |
p. S530
|
artikel
|
| 2457 |
RWD148 Using Linked Data: Agreement in Diagnosis for Patients with Asthma or Diabetes
|
Costantino, H.
|
|
|
26 |
12S |
p. S532-S533
|
artikel
|
| 2458 |
RWD154 Using Real World Evidence from the UK MS Register to Support Optimal Healthcare Decision Making
|
Bhatt, N.
|
|
|
26 |
12S |
p. S534
|
artikel
|
| 2459 |
RWD155 Using Real-World-Evidence to Inform Pathway Evaluations at NICE: Benefits and Challenges
|
Brooke, A.
|
|
|
26 |
12S |
p. S534
|
artikel
|
| 2460 |
RWD174 Using Real-World Evidence to Quantify Hospital Costs of Subcutaneous Implantable Cardioverter-Defibrillator Infections in the US
|
Margetta, J.
|
|
|
26 |
12S |
p. S538
|
artikel
|
| 2461 |
RWD44 Utilization of Short-Term and Long-Term Disability, and Workers' Compensation in Employees with Major Depressive Disorder Compared with Employed Controls
|
Brook, R.A.
|
|
|
26 |
12S |
p. S512
|
artikel
|
| 2462 |
RWD41 Utilization Patterns of Glucagon-like Peptide Receptor Agonists in Patients with Type 2 Diabetes in France and Italy
|
Khare, S.
|
|
|
26 |
12S |
p. S512
|
artikel
|
| 2463 |
RWD12 Wayfind-R: A Global, Real-World Precision Oncology Registry – Socioeconomic Features
|
Hackshaw, A.
|
|
|
26 |
12S |
p. S506
|
artikel
|
| 2464 |
SA78 Active Participation of Children in Health Research: Methods, Experience and Ethical Aspects
|
Steinbeck, L.
|
|
|
26 |
12S |
p. S557
|
artikel
|
| 2465 |
SA2 A Meta-Regression Tool: Assessing the Relationship Between Risk Factors and Events Development
|
Li, X.
|
|
|
26 |
12S |
p. S541
|
artikel
|
| 2466 |
SA62 A Methodological Approach for the Design of a Unique Post Market Clinical Follow-up Study for Standard and Custom-Made Devices According to EU Medical Device Regulation 2017/745
|
Simoni, L.
|
|
|
26 |
12S |
p. S553
|
artikel
|
| 2467 |
SA17 Application of CPRD Data in NICE Submissions: Model Inputs for Functional Health States
|
Marks, T.
|
|
|
26 |
12S |
p. S544
|
artikel
|
| 2468 |
SA58 Approaches to Examine Treatment Adherence and Persistence Using German Claims Data: An Exemplary Analysis Using Oral Therapies for Prostate Cancer
|
Junker, S.
|
|
|
26 |
12S |
p. S552
|
artikel
|
| 2469 |
SA37 A Real-World Evaluation of People with Drug-Resistant Focal Epilepsy Across Six European Countries
|
Boccaletti, S.
|
|
|
26 |
12S |
p. S548
|
artikel
|
| 2470 |
SA73 A Retrospective Cohort Study to Evaluate the Disease Burden, Treatment Patterns, Healthcare Resource Utilization, and Costs in Patients with Breast Cancer in Dubai, United Arab Emirates
|
Hamza, D.M.M.
|
|
|
26 |
12S |
p. S555-S556
|
artikel
|
| 2471 |
SA16 Assessing the Validity of Observational Filters for Systematic and Rapid Literature Reviews
|
Smela, B.
|
|
|
26 |
12S |
p. S543-S544
|
artikel
|
| 2472 |
SA74 A Systematic Literature Review to Assess the Level of Evidence in Facioscapulohumeral Muscular Dystrophy
|
Barnieh, L.
|
|
|
26 |
12S |
p. S556
|
artikel
|
| 2473 |
SA30 A Systematic Review of the Use of Registry-Based Randomized Controlled Trials (R-RCTs) for Regulatory Approval and Access
|
Zhao, J.
|
|
|
26 |
12S |
p. S547
|
artikel
|
| 2474 |
SA11 A Systematic Review on the Safety and Effectiveness of the Active Middle Ear Implant in the Treatment of Conductive and Mixed Hearing Loss
|
Park, E.
|
|
|
26 |
12S |
p. S542-S543
|
artikel
|
| 2475 |
SA15 A Systematic Review to Assess How Cure Is Modelled and Subsequently Evaluated in Health Technology Submissions to the National Institute for Health and Care Excellence (NICE)
|
Wigfield, P.
|
|
|
26 |
12S |
p. S543
|
artikel
|
| 2476 |
SA19 Biologics Sequencing in Clinical Units (BISCUITS): UK IBD Registry Agile Research
|
Bartalucci, G.
|
|
|
26 |
12S |
p. S544
|
artikel
|
| 2477 |
SA23 Bruton Tyrosine Kinase Inhibitor (BTKi) Monotherapy for the Treatment of ‘High-Risk’ Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL): A Systematic Literature Review (SLR)
|
Mohseninejad, L.
|
|
|
26 |
12S |
p. S545
|
artikel
|
| 2478 |
SA24 Can an Integrated Systematic Literature Review (SLR) Database Improve the Speed of Title and Abstract (TIAB) Review? A Case Study Using Multiple Myeloma (MM) Projects in Interventional and Real-World Evidence (RWE) Evidence
|
Liu, R.
|
|
|
26 |
12S |
p. S545
|
artikel
|
| 2479 |
SA13 Can Models for Surrogate Endpoint Evaluation Be Used to Predict Generic Measures From Disease Specific Measures of Health Related Quality of Life Based on Summary Data?
|
Sadek, A.
|
|
|
26 |
12S |
p. S543
|
artikel
|
| 2480 |
SA49 Capturing Real-World Evidence Alongside Trial Evidence in HTA-Specified Systematic Literature Review: Optimizing Search Strategies across the Totality of Evidence Required
|
Field, P.
|
|
|
26 |
12S |
p. S550
|
artikel
|
| 2481 |
SA25 Caregiver Burden in Growth Hormone Deficiency: A Targeted Review
|
Amini, F.
|
|
|
26 |
12S |
p. S546
|
artikel
|
| 2482 |
SA4 Characterization of Demography and Comorbidity in Newly Diagnosed Multiple Myeloma Patients in the UK
|
Tunaru, F.
|
|
|
26 |
12S |
p. S541
|
artikel
|
| 2483 |
SA70 Clinical Benefits and Cost-Effectiveness of High-Dose Capsaicin Cutaneous Patches for Peripheral Neuropathic Pain: A Literature Review
|
Schubert, T.
|
|
|
26 |
12S |
p. S555
|
artikel
|
| 2484 |
SA44 Clinical Burden of Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Focused Literature Review
|
Mayen Herrera, E.
|
|
|
26 |
12S |
p. S549-S550
|
artikel
|
| 2485 |
SA59 Clinical Evidence on Acanthamoeba Keratitis Treatments: Systematic Literature Review
|
Tofani, L.
|
|
|
26 |
12S |
p. S552-S553
|
artikel
|
| 2486 |
SA52 Clinical Impact of Using Digital Healthcare Technology to Manage Diabetes in Adolescents.: A Systematic Review and Meta-Analysis
|
Park, J.
|
|
|
26 |
12S |
p. S551
|
artikel
|
| 2487 |
SA48 Comparative Effectiveness Based on Win Ratios: Do Conventional ITC Approaches Work?
|
Ishak, K.J.
|
|
|
26 |
12S |
p. S550
|
artikel
|
| 2488 |
SA67 Considerations for Including Different Routes of Administration in Network Meta-Analysis: A Comprehensive Review
|
Powell, L.
|
|
|
26 |
12S |
p. S554
|
artikel
|
| 2489 |
SA68 Consistency Between Network Meta-Analysis and Real-Word Data Analysis: Comparison of Changes in Hemoglobin A1c Levels After Treatment with Metformin Vs the Other Oral Antidiabetics in Japanese Patients with Type 2 Diabetes
|
Nakamura, M.
|
|
|
26 |
12S |
p. S554
|
artikel
|
| 2490 |
SA6 Cost-of-Illness of Skin Cancer: A Systematic Literature Review
|
Meertens, A.
|
|
|
26 |
12S |
p. S542
|
artikel
|
| 2491 |
SA72 Current Practices for the Selection of Effect Modifiers and Confounders in Population-Adjusted Indirect Comparisons (PAIC): A Review of Technology Appraisals (TA)
|
Chandler, C.
|
|
|
26 |
12S |
p. S555
|
artikel
|
| 2492 |
SA51 Definition and Methodology of Rapid Literature Reviews
|
Smela, B.
|
|
|
26 |
12S |
p. S551
|
artikel
|
| 2493 |
SA12 Discrepancy of Health State Utility Values in Cost-Utility Analyses of Interventions Against Infectious Diseases in Older Adults
|
Pham, T.H.
|
|
|
26 |
12S |
p. S543
|
artikel
|
| 2494 |
SA61 Economic Burden of Patients in the United States with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Focused Literature Review
|
Mayen Herrera, E.
|
|
|
26 |
12S |
p. S553
|
artikel
|
| 2495 |
SA50 Economic Evaluation of Robotic-Assisted Surgery: Methods, Challenges, and Opportunities
|
Lai, T.
|
|
|
26 |
12S |
p. S550-S551
|
artikel
|
| 2496 |
SA7 Emerging Biomarkers in Metastatic Castration Resistant Prostate Cancer As Evaluated in Early Phase Clinical Trials: A Targeted Literature Review
|
Lee, L.J.
|
|
|
26 |
12S |
p. S542
|
artikel
|
| 2497 |
SA29 Evaluating the Adherence to ISPOR Guidelines in Globally Published Budget Impact Analyses of New Drugs: A Targeted Literature Review
|
Amaefule, A.
|
|
|
26 |
12S |
p. S546-S547
|
artikel
|
| 2498 |
SA28 Evaluation of Disease Epidemiology, Comorbidities, Treatment Patterns, and Healthcare Resource Utilization of Alopecia Areata in United Arab Emirates: A Retrospective Claims Database Study
|
Al Hammadi, A.
|
|
|
26 |
12S |
p. S546
|
artikel
|
| 2499 |
SA66 Expert Elicitation Techniques: Informing Application in HTA Decision-Making
|
Riley, D.
|
|
|
26 |
12S |
p. S554
|
artikel
|
| 2500 |
SA32 Exploring the Feasibility of Indication-Based Pricing in the Korea Healthcare System: A Survey Study
|
Kim, B.R.M.
|
|
|
26 |
12S |
p. S547
|
artikel
|
| 2501 |
SA47 Exploring the Use of Health Technology Assessment in Uganda’s Health Policy and Financing Decision-Making Processes
|
Kirabo-Nagemi, C.
|
|
|
26 |
12S |
p. S550
|
artikel
|
| 2502 |
SA21 Feasibility Assessment of an Indirect Treatment Comparison (ITC) of Sacituzumab Govitecan (SG) Vs Trastuzumab Deruxtecan (T-DxD) in HR+/HER2– Metastatic Breast Cancer (mBC)
|
Shah, A.
|
|
|
26 |
12S |
p. S545
|
artikel
|
| 2503 |
SA81 Has the Publication of China Guidelines for
Pharmacoeconomic Evaluations 2020 influenced the Study Quality of Economic Evaluations in China? A Systematic Review
|
Cao, S.
|
|
|
26 |
12S |
p. S557
|
artikel
|
| 2504 |
SA77 Health Technology Assessment (HTA) Feasibility Study: The XprESS Device for the Treatment of Patients With Eustachian Tube Dysfunction
|
Antonini, D.
|
|
|
26 |
12S |
p. S556-S557
|
artikel
|
| 2505 |
SA69 Impact of COVID-19 on Health Care Resource Utilization and Costs in Patients With Chronic Obstructive Pulmonary Disease and Asthma in the United States (2018–2022): A Population-Based Study
|
Lee, L.Y.
|
|
|
26 |
12S |
p. S555
|
artikel
|
| 2506 |
SA5 Innovative Direct-to-Physician Retrospective Chart Review Approach: Synthesized Learnings from Completed and Ongoing
|
Brett, N.
|
|
|
26 |
12S |
p. S541
|
artikel
|
| 2507 |
SA1 In Silico Clinical Trials Using Mechanistic Knowledge-Based Model, an Innovative Approach to Accelerate Data Generation and Support Health Technology Assessment
|
Pham, E.
|
|
|
26 |
12S |
p. S541
|
artikel
|
| 2508 |
SA14 "I've Got a Text!” Feedback from Prospective Participants on the Use of SMS Surveys in Real-World Studies
|
Lawrence, J.
|
|
|
26 |
12S |
p. S543
|
artikel
|
| 2509 |
SA60 Key Challenges in Gene Therapy Development for Usher Syndrome: Insights from Machine-Assisted Rapid Scoping Review
|
Bhat, R.
|
|
|
26 |
12S |
p. S553
|
artikel
|
| 2510 |
SA83 {Maicplus}: An R Package to Support Analysis and Reporting of Matching Adjusted Indirect Treatment Comparisons (MAIC) for HTA Dossiers
|
Chen, G.
|
|
|
26 |
12S |
p. S558
|
artikel
|
| 2511 |
SA27 Menopause: More Than Just Vasomotor Symptoms
|
Malacan, J.
|
|
|
26 |
12S |
p. S546
|
artikel
|
| 2512 |
SA43 Methods of Estimating Annualized Bleed Rates from Medical Records Among Patients with Hemophilia A
|
Liao, N.S.
|
|
|
26 |
12S |
p. S549
|
artikel
|
| 2513 |
SA45 Natural Evolution of Chronic Kidney Disease in Diabetic Patients: Costs and Consequences in Portuguese Reality
|
Silva Miguel, L.
|
|
|
26 |
12S |
p. S550
|
artikel
|
| 2514 |
SA41 Novel Method for Indirect Comparison of Treatment Sequences Using Averaged Parametric Survival Models with Application to Hepatocellular Carcinoma
|
Aceituno, D.
|
|
|
26 |
12S |
p. S549
|
artikel
|
| 2515 |
SA79 Opportunities and Challenges for Decentralized Clinical Trials: European Health Technology Assessment Perspective
|
de Jong, A.
|
|
|
26 |
12S |
p. S557
|
artikel
|
| 2516 |
SA38 Out-of-Pocket Expenses and Lost Earnings for Breast Cancer Patients Undergoing Treatment: Evidence From the UK Persephone Randomised Controlled Trial Abstract
|
Alzehr, A.
|
|
|
26 |
12S |
p. S548
|
artikel
|
| 2517 |
SA40 Patient-Level Simulation Models in Cancer Care
|
Busschaert, S.L.
|
|
|
26 |
12S |
p. S549
|
artikel
|
| 2518 |
SA63 Planning Phase 3 Clinical Trials More Efficiently Using an Evidence-Mapping Approach
|
Rutherford, L.
|
|
|
26 |
12S |
p. S553
|
artikel
|
| 2519 |
SA26 Prevalence and Burden of Lupus in Adult French Population: A Retrospective Longitudinal National Hospital Claims Study
|
Cohen, N.
|
|
|
26 |
12S |
p. S546
|
artikel
|
| 2520 |
SA80 Priors on Between-Study Heterogeneity in Bayesian Meta-Analysis Models: A Simulation Study Using Hamiltonian Monte Carlo Sampling
|
Dunnewind, N.
|
|
|
26 |
12S |
p. S557
|
artikel
|
| 2521 |
SA42 Project SATURN – A Real-World Evidence and Data Collaboration With Existing European Datasets in Osteogenesis Imperfecta to Support Future Therapies
|
Sangiorgi, L.
|
|
|
26 |
12S |
p. S549
|
artikel
|
| 2522 |
SA18 Public Health Economic Modelling in Evaluations of Salt and Alcohol Policies: A Scoping Review
|
Mensah, J.
|
|
|
26 |
12S |
p. S544
|
artikel
|
| 2523 |
SA54 Quality of Life, Economic Burden, and Comorbidities Associated with Essential Tremor: A Systematic Literature Review
|
Mitchell, S.A.
|
|
|
26 |
12S |
p. S551
|
artikel
|
| 2524 |
SA71 Real-World Treatment Patterns for Acute Lymphoblastic Leukemia Utilizing Claims Data
|
Menon, J.
|
|
|
26 |
12S |
p. S555
|
artikel
|
| 2525 |
SA36 Safety, Efficacy, Quality of Life, and Treatment Dynamic of Conventional Therapies for Adults and Adolescents Suffering From Eosinophilic Esophagitis, a Type 2 Inflammatory Disease: Qualitative and Quantitative Synthesis
|
Povero, M.
|
|
|
26 |
12S |
p. S548
|
artikel
|
| 2526 |
SA64 Systematic Literature Review of Measurement and Valuation Methods for Societal Costs: A Focus on Cost-Effectiveness Analyses of Three Types of Disease Potentially Associated with High Spillover Effects
|
Primel, R.
|
|
|
26 |
12S |
p. S554
|
artikel
|
| 2527 |
SA76 Systematic Literature Review on Economic Burden of Retinitis Pigmentosa (RP) and Visual Impairment in France
|
Breau-Brunel, M.
|
|
|
26 |
12S |
p. S556
|
artikel
|
| 2528 |
SA31 Systematic Versus Rapid Reviews: The Impact of Different Methodologies on the Reviews’ Conclusions
|
Smela, B.
|
|
|
26 |
12S |
p. S547
|
artikel
|
| 2529 |
SA82 Systematic Versus Rapid Review: The Impact of Database Coverage and Single Studies Selection on the Review's Conclusions
|
Smela, B.
|
|
|
26 |
12S |
p. S558
|
artikel
|
| 2530 |
SA39 Targeted Treatments for Patients with Relapsed and/or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): A Systematic Literature Review (SLR) of Randomized Clinical Trials (RCTs)
|
Mohseninejad, L.
|
|
|
26 |
12S |
p. S548-S549
|
artikel
|
| 2531 |
SA22 Tepotinib Versus Chemotherapy in Met Exon 14 (METex14) Skipping Non-Small Cell Lung Cancer (NSCLC): Real-World Evidence (RWE) and Matching-Adjusted Indirect Comparison (MAIC) to Explore the Impact of Subsequent Therapy
|
Wheat, H.
|
|
|
26 |
12S |
p. S545
|
artikel
|
| 2532 |
SA53 The Accuracy of Network Meta-Analysis Feasibility Predictions Based on Data Included Only in the Abstracts of Trial Publications
|
Rutherford, L.
|
|
|
26 |
12S |
p. S551
|
artikel
|
| 2533 |
SA10 The Burden of Illness of Vasomotor Symptoms Associated with Menopause
|
Malacan, J.
|
|
|
26 |
12S |
p. S542
|
artikel
|
| 2534 |
SA34 The Cost-Effectiveness of Community Health Workers in Primary Health Care: A Systematic Literature Review
|
Van Iseghem, T.
|
|
|
26 |
12S |
p. S547-S548
|
artikel
|
| 2535 |
SA20 The Effectiveness and Safety of Intra-Articular Injection Using Collagen in Knee Osteoarthritis: Systematic Review
|
Park, E.
|
|
|
26 |
12S |
p. S544
|
artikel
|
| 2536 |
SA33 The Role of Artificial Intelligence in Decoding the Placebo Response - Implications for Clinical Research and Practice
|
Nass, P.
|
|
|
26 |
12S |
p. S547
|
artikel
|
| 2537 |
SA8 The Use of Care Pathway Analysis to Inform Health Economic Models and Evidence Generation Requirements: Practical Applications and Examples from Two Projects
|
Gregg, E.
|
|
|
26 |
12S |
p. S542
|
artikel
|
| 2538 |
SA75 The Use of Formal Expert Opinion Elicitation to Inform Model Structure and Inputs in Rare Diseases
|
Gregg, E.
|
|
|
26 |
12S |
p. S556
|
artikel
|
| 2539 |
SA56 Treatment Patterns of Advanced Egfr-Positive Non-Small Cell Lung Cancer (NSCLC) in Latin America
|
Alves, J.S.
|
|
|
26 |
12S |
p. S552
|
artikel
|
| 2540 |
SA65 Trends in the Systematic Literature Reviews Over the Years
|
Smela, B.
|
|
|
26 |
12S |
p. S554
|
artikel
|
| 2541 |
SA57 Unmet Needs and Evidence Gaps in Relapsed/Refractory Marginal Zone Lymphoma: Findings from a Systematic Literature Review
|
Mohseninejad, L.
|
|
|
26 |
12S |
p. S552
|
artikel
|
| 2542 |
SA55 Whole-Body MRI Accuracy and Cost-Effectiveness Compared with Standard Pathways for Detecting and Monitoring Bone Metastases in Prostate Cancer: A Systematic Review
|
Zamora Talaya, B.
|
|
|
26 |
12S |
p. S551-S552
|
artikel
|
Tijdschrift beschrijving